TSANZ home

Results for "TSANZ Awards by Nomination"

Home 5 Search query for: TSANZ Awards by Nomination
Results for "TSANZ Awards by Nomination"
VOLUME 5.04 – JUNE 2020

VOLUME 5.04 – JUNE 2020

Research Roundup:

June 2020

 

Welcome Message

Welcome to this exciting update of the Research Roundup.

Many of you would have experienced the success of our first virtual Ann Woolcock Award presentation session. I congratulate all the finalists for adapting so well to this new format and to the audience who quickly settled into the Zoom Q&A system and challenged the speakers with stimulating questions.

The RSC members are having a well-earned break from their arduous but rewarding grant review duties, and both I and the Society sincerely thank these members for all their hard work. Their break will be short as awards will open again in the coming months.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the June edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

2020 Respiratory Research Excellence Awards

 

TSANZ congratulates the following award winners!!!

 

Ann Woolcock New Investigator Award Winner: Kurtis Budden

Ann Woolcock New Investigator Award Finalists: Kak-Ming Ling, Rebecca Stockwell, Steven Taylor, Pamela Laird, Razia Zakarya

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship: Simon Craig

TSANZ/AstraZeneca Respiratory Research Mid-Career Fellowship: Hayley Scott

TSANZ/AstraZeneca Respiratory Research Early Career Fellowship: Steven Taylor

Australian Cystic Fibrosis Research Trust 2020 Innovation Grant: Abdullah Tarique, Peter Sly, Emmanuelle Fantino, Clair Wainwright, and Scott Bell

Vertex Adult Cystic Fibrosis Research Award: Sandra Hodge, Peter Zalewski, David Parsons, Andrew Tai, Sally Chapman, Judith Morton, and Emily Hopkins

Vertex Paediatric Cystic Fibrosis Research Award: Shafagh Waters and Adam Jaffe

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease: Mariane T Turner, Samuel Sameh, Robert A Cohen, and Deborah H Yates           

TSANZ Rob Pierce Grant-In-Aid for Indigenous Lung Health: Kristin Carson-Chahhoud

TSANZ Peter Phelan Paediatric Research Award: Shivanthan Shanthikumar

TSANZ / Boehringer Ingelheim Australia COPD Travel Award: Katrina Tonga

TSANZ / Boehringer Ingelheim New Zealand COPD Travel Award: Hajar Ali

TSANZ/JRS Early Career Development Award: Saleela Ruwanpura

Janet Elder International Mid-Career Travel Award: David G Chapman

Janet Elder International Early Career Travel Award Recipient 1: Steven Taylor

Janet Elder International Early Career Travel Award Recipient 2: Tony Zhang

TSANZ Respiratory Nurses Career Development Award for Indigenous Research:Kobi Schutz

 

TSANZ would like to thank our partners and sponsors for their support of excellent respiratory research and researchers!

2020 TSANZ Awards by Nomination

At TSANZ 2020 AGM we recognised seven leaders in their field of lung health.

TSANZ 50th Anniversary Medal for Education and Training – Associate Professor David Fielding.

The 50th Anniversary Medal is awarded each year in recognition of outstanding contributions to respiratory education and training in Australia or New Zealand.

TSANZ Research Medal – Professor Shyamali Dharmage, Professor Alan James

This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand. This year, due to the calibre of nominations, the TSANZ Board has chosen two recipients for the TSANZ Research Medal.

TSANZ Society Medal – Associate Professor Tara Mackenzie

This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand.

Fellowships

  • Professor Richard Beasley
  • Professor Margaret Wilsher
  • Professor Ross Vlahos

Each year the TSANZ board considers peer nominations for Fellow status of the Thoracic Society of Australia and New Zealand (TSANZ). Fellow status is awarded to members who have demonstrated exceptional contributions to the field of respiratory health in Australia or New Zealand.

Congratulations to all!

Respirology – Editor’s Choice 

Respirology Issue 25.5 May 2020

 

Artificial stone-associated silicosis in China: A prospective comparison with natural stone-associated silicosis

Na Wu, Changjiang Xue, Shiwen Yu and Qiao Ye

 

Chest HRCT of 2 peatients with natural stone-associated findings (top) and 2 patients with artificial stone-associated silicosis (Bottom)

DOI: 10.1111/resp.13744

 

Acute exacerbations of fibrotic interstitial lung diseases

Atsushi Suzuki, Yasuhiro Kondoh, Kevin K. Brown, Takeshi Johkoh, Kensuke Kataoka, Junya Fukuoka, Tomoki Kimura, Toshiaki Matsuda, Toshiki Yokoyama, Jun Fukihara, Masahiko Ando, Tomonori Tanaka, Naozumi Hashimoto, Koji Sakamoto and Yoshinori Hasegawa

 

Researchers from the ILD collaborative team from Japan and US. From left to right: (front) Dr. Yasuhiro Kondoh, Dr. Kevin K. Brown, Dr. Yoshinori Hasegawa; (back) Dr. Atsushi Suzuki, Dr. Koji Sakamoto, Dr. Naozumi Hashimoto, Dr. Kensuke Kataoka, Dr. Yuji Saito.

DOI: 10.1111/resp.13682

Respirology Issue 25.6 June 2020

 

Effects of E-cigarette E-liquid components on bronchial epithelial cells: Demonstration of dysfunctional efferocytosis

Miranda P. Ween, Rhys Hamon, Matthew G, Macowan, Leigh Thredgold, Paul R. Reynolds and Sandra J. Hodge

 

A collection of e-cigarettes and e-liquids for sale to vapers

DOI: 10.1111/resp.13696

 

Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF

Erica Farrand, Eric Vittinghoff, Brett Ley, Atul J. Butte and Harold R. Collard

 

 

The research team from the University of California San Francisco in the United States (c269928 represents Brett Ley)

DOI: 10.1111/resp.13753

TSANZSRS 2020 Abstracts

Due to the COVID-19 pandemic, the TSANZSRS 2020 ASM has been postponed until 30 April – 4 May 2021. This supplement contains Abstracts that were accepted for presentation at the 2020 meeting.

Volume 25, Issue S1 TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, 27–31 March 202

 

Invitations and surveys

 

CYSTIC FIBROSIS RESEARCH AND ADVOCACY PRIORITY SETTING SURVEY 2020 AND BEYOND

Dear Members of the Thoracic Society of Australia and New Zealand,

Cystic Fibrosis Australia (CFA) is inviting the TSANZ members to take part in their Research and Advocacy Priority Setting survey. If you are a CF stakeholder, living with the condition or looking after someone who lives with the condition, then your survey responses are greatly needed and encouraged.

https://www.surveymonkey.com/r/F38Q8K2

We want all our community members, patients, carers, clinicians and researchers to be involved in every step and we thank you for agreeing to take part.

To speak to us about this questionnaire or for any further enquires, contact us at (02) 9889 5171 or email nickim@cfa.org.au. Alternatively, you can join the conversation over at the Cystic Fibrosis Australia page on Facebook.

 

INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

Dear colleagues,

Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

  • 1-3: Outcomes of limited importance.
  • 4-6: Outcomes that are important but not critical.
  • 7-9: Critical outcomes.

We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

Your opinion in both surveys is extremely important in developing the core outcome set.

It is crucial that you complete both surveys and we would be very grateful if you can do this.

Please, take the survey in one of the following languages:

English: https://delphimanager.liv.ac.uk/COPD/
Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
German: https://delphimanager.liv.ac.uk/COPD-GE/
Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
Russian: https://delphimanager.liv.ac.uk/COPD-RU/
Greek: https://delphimanager.liv.ac.uk/COPD-GR/
Danish: https://delphimanager.liv.ac.uk/COPD-DK/
Italian: https://delphimanager.liv.ac.uk/COPD-IT/

We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

Thank you very much in advance,
Kind regards,
Associate Prof. Jens-Ulrik Jensen,
Dr. Alexander Mathioudakis,
Prof. Jørgen Vestbo,
On behalf of the study team.

 

NURSES’ ATTITUDES TO CARING FOR PEOPLE WITH INTELLECTUAL DISABILITY: AN AUSTRALIAN SURVEY

Dear Colleagues,

We invite you to consider participating in our online survey focused on nurses’ attitudes to caring for people with intellectual disability. This survey, led by researchers from Western Sydney and Central Queensland Universities, is a replication of a previous US study by Dr Melissa Desroches from the University of Massachusetts, Dartmouth.

People with intellectual disability have lower levels of general health than other members of our community. They also have higher incidence of hospitalisation and, of major concern, higher incidence of preventable death than members of the general population.

By learning about nurses’ attitudes to caring for people with intellectual disability, we anticipate being able to develop models of care and supportive resources for nurses to enhance the care that they provide to people with intellectual disability.

Please read the attached participant information sheet and consider completing this short survey by accessing the link below:

Caring for People with Intellectual Disability survey

Thank you for considering our invitation
A/Prof Nathan Wilson, Western Sydney University
Dr Peter Lewis, Western Sydney University
Ms Virginia Howie, Central Queensland University
Dr Melissa Desroches, University of Massachusetts, Dartmouth

Kind regards,
Virginia

 

GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

Dear Colleague, 

You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

THANK YOU!
Jaber Alqahtani
On behalf of the whole international team

 

INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

Dear Members of the Thoracic Society of Australia and New Zealand, 

Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

If you are interested in participating or would like further information on this study, please contact: 

Professor Anne Holland (Chief Investigator) 
Professor of Physiotherapy, 
Monash University and Alfred Health 
Email: Anne.Holland@monash.edu 
Telephone: (03) 9903 0214 

Ms Joanna Lee (PhD candidate)
Monash University and Alfred Health
Email: joanna.lee2@monash.edu
Mobile: 0431 689 361

Thank you for your time and consideration of our study. 

 

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland
Professor of Physiotherapy, Monash University and Alfred Health
Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University
Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

 

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

 

.

 

VOLUME 5.04 – JUNE 2020

VOLUME 2.8 OCTOBER 2017

Research Roundup:

October  2017

.
 

Welcome Message

Please be reminded, the Thoracic Society Awards for Research and Career Development are open until the 13th of November. Some awards are new and some are different to previous years. We would like to encourage you to have a look below at the Open Awards and see which ones may help you in your research endeavours.

We would also like to draw your attention to the NHMRC Peer Review Consultation which is now open on the NHMRC Public Consultations Portal. The consultation paper is available here. TSANZ will submit a response to this consultation on behalf of the society and you are encouraged to send in your opinion to the office to ensure our response is representative of our membership. Please let us know your opinion on the NHMRC peer review paper by the 17th of November by responding to hayley.see@thoracic.org.au

Enjoy the October edition of your research roundup. This edition is focused on awards so please delve into the opportunities below as they span many area of research and different career stages.

Prof Phil Hansbro

Prof Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Research and Career Development Awards now open

TSANZ Peter Phelan Research Award

TSANZ Indigenous Respiratory Nursing Award

TSANZ / National Asthma Council Australia – Asthma and Airways Fellowship

Boeringher Ingelheim COPD Research Award

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health

TSANZ/LFA CSL Behring Research Award for Alpha-1 anti-trypsin deficiency 

TEVA Scholar Award for APSR

Awards close 13 November 2017

For more information visit https://www.thoracic.org.au/researchawards/tsanz-awards

More coming soon!

 

Lung Foundation Australia Awards

Lung Foundation Australia / Cochrane Airways Australia Scholarship 2018

Lung Foundation Australia and Cochrane Airways Australia invite applications for the Lung Foundation Australia/Cochrane Airways Australia Scholarship 2018 valued at $2,500. This scholarship is intended to assist with the completion, update and/or presentation of a Systematic Review. Cochrane Review Scholarships have been awarded on an annual basis since 2001, and have been highly productive.

A Cochrane review is an ideal topic for an advanced trainee in any health profession, or when initiating a PhD program, as most reviews can be completed within a year. Completed reviews are published on the Cochrane Database of Systematic Reviews (Impact Factor 6.124 effective July 2016) and indexed in Medline. Conducting a review provides experience in critical appraisal of the literature, and other aspects of Evidence-Based Medicine.

MORE INFORMATION

Re-launched: Lung Foundation Australia and the Better Breathing Foundation Allied Health PhD Scholarship in Chronic Lung Disease – 2018/2021

Valued at $20,000 per year for four years for a full-time student (total funding $80,000) or $10,000 per year for four years for a part-tome student (total funding $40,000). Co-funding from a University is optional but desirable.

Deadline 6 November 2017

Partnership form | Application form

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

TSANZ Awards by Nomination

Deadline midnight AEDT Sunday 29 October

The Society Medal

The Society Medal was conceived as an acknowledgment of excellence in fields other than research, i.e. for the advancement of the practice of thoracic medicine in its widest sense by outstanding teaching or advocacy.

The Research Medal

The Research Medal is awarded in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in their field of research.

The 50th Anniversary Medal for Education & Training

The 50th Anniversary Medal for Education & Training was introduced in 2011 to mark the Society’s 50th Anniversary. The 50th Anniversary Medal is awarded in recognition of outstanding contributions to respiratory education and training in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in education and training.

This might take the form of formal and informal teaching within a university, hospital or other health care setting; curriculum development at an undergraduate or postgraduate level; using research to enhance the efficacy of educational activities; career mentoring of junior members of the Society; integration of teaching into clinical practice; or advocacy on behalf of medical education as applied to respiratory medicine.

 

New NHMRC grant program public consultation on peer review

NHMRC invites submissions to its consultation paper on peer review in the new grant program. Submissions close 5:00pm (AEDT) on Monday 4 December 2017.

To complement the consultation paper, NHMRC is hosting a series of public forums across Australia between 29 September and 24 November 2017 on elements of peer review. Registrations are currently being accepted.

TSANZ will submit a response to this consultation on behalf of the society and you are encouraged to send in your opinion to the office to ensure our response is representative of our membership. Please let us know your opinion on the NHMRC peer review paper by the 17th of November by responding to hayley.see@thoracic.org.au

Grant Bulletin

This grant bulletin contains direct-to-researcher grants and awards due in 2017:

Bill & Melinda Gates Foundation Grand Challenges Explorations Round 20 – closes 08/11/17
Early-stage innovative research projects from a range of disciplines and regions. The challenges for Round 20 are: Healthy Minds for Adolescent Mothers: Achieving Healthy Outcomes for the Family; Innovations for Integrated Diagnostics Systems; Novel Approaches for Improving Timeliness of Routine Immunisation Birthdose and Healthcare Worker Skill in Low-Resource Settings.

Integra Underground Community Investment – closes 01/12/17
Funding is provided for the following focus areas: Capacity Building, including education/training, enterprise development, and economic diversification; Health; Environment.

Pro Bono Australia – Impact 25 Awards (2017) – closes 01/12/17
Award to name the year’s most influential people who have made a significant and positive impact. Nominees should embody the principles of integrity, initiative, foresight, and collaboration.

Auswide Community Grants Scheme –  closes 01/12/17.
Supports local activities, organisations, events and projects covering a wide range of sporting, cultural and community interests and endeavours. Includes community services, events and celebrations, buildings, public spaces and facilities, research, and organisational development.

Australian Respiratory Council Harry Windsor Research Grants Scheme – closes 07/12/17
For projects which address research in tuberculosis, respiratory diseases due to other infections, or respiratory diseases related to tobacco use. Within these categories, projects examining TB/HIV, community issues or the health of disadvantaged groups that relate to the work that the ARC undertakes within Australia and the Pacific Region are particularly encouraged. The proposals can encompass clinical research, public health research or basic scientific research. Grants are available for projects submitted to the National Health and Medical Research Council (NHMRC) which are considered fundable but which do not reach the cut-off mark for funding in any one year.

Perpetual Trustees 2018 IMPACT Philanthropy Application Program – closes 08/12/17
Perpetual distributes to all sectors including social welfare, health, medical research, conservation and environment, education, and arts and culture. As is consistent with Perpetual’s IMPACT Philanthropy Application Program process, an organisation’s submission will be assessed against Leadership, Capability, Strategy and Outcomes. Further 2018 information will be released later in 2017.

Allen Foundation Grants (2018) – closes 31/12/17
Priorities are: to fund relevant nutritional research; to support programs for the education and training of mothers during pregnancy and after the birth of their children; to assist in the training of persons to work as educators and demonstrators of good nutritional practices; to encourage the dissemination of information regarding healthful nutritional practices and habits; in limited situations to make grants to help solve immediate emergency hunger and malnutrition problems.

Rolling Grants

John Templeton Foundation
Interest areas are: science and the big questions; character virtue development; freedom and free enterprise; exceptional cognitive talent and genius; genetics; voluntary family planning.

Boehringer Ingelheim Fonds Travel Grants
Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

Baxalta Bioscience Grants – Medical Education & Fellowship Grants
Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

The Balnaves Foundation
The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma. This is the first round of a multi-national Delphi process to reach a consensus and there will be follow-up questions based on the answers we receive from round one (with likely three rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Research Masters degree by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=l6M2m5m3

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai 
JamesMichael.Ramsahai@uon.edu.au

 

Case Management of Venous thromboembolism

Many thanks for your time in completing this short survey, which should take no longer than 5 minutes. At St. John of God, we are exploring the management of VTE in patients with or without malignancy and in the perioperative setting.

We appreciate there are a large number of guidelines, many of which can be contradictory in their recommendation. Irrespective of this, we would greatly value your feedback on how you would manage the following cases, recognising that several answers may be appropriate.

This survey consists of 4 short cases which will cover a range of clinical scenarios with regards the management of VTE in the immediate post-operative and preoperative period, as well as the management of VTE in the setting of suspected and confirmed solid organ malignancy.

https://www.surveymonkey.com/r/IVCFilter

All results are completely anonymised and your participation is greatly appreciated.

Kind regards,

Prof Eli Gabbay egabbay@respiratorywest.com.au
Dr Philip Craven

Australian Society for Medical Research National Scientific Conference

Held in Sydney, at the Charles Perkins Centre, from November 14th to 15th, 2017 the NSC has an exciting new design all packed up in a shorter format.

In these highly competitive times, the NSC 2017 will fulfil an important yet unmet need for early to mid career health and medical researchers.

Entitled “Science and Survival – equipping you with the tools to further your research career” the aims of the  conference are:

  • To empower and inspire our present and future scientific leaders.
  • To provide a springboard for early to mid-career researchers to showcase their research.
  • To promote scientific excellence, collaboration and transdisciplinary research.
  • To upskill in grantsmanship and understand the promotion process.
How are we going to achieve this?

We are very excited about the new format of NSC 2017 with both scientific presentations and visionary professional development workshops.

Conference highlights

Mock GRP session with all the elements of a GRP and the perspective of a narrator.

Inside the scientist studio – Norman Swan  interviews Nobel Prize Winner Professor Peter Doherty.

Politics of promotion to provide invaluable insights into the intricate and necessary journey to Associate Professorship.

The Edwards Orator is Distinguished Professor Jagadish Chennupati from ANU. A stellar transdisciplinary researcher and a nanotechnology pioneer. ­­­He is also a charismatic leader and mentor who will inspire our participants.

Dr Bon-Kyoung Koo from the University of Cambridge will deliver the Firkin Oration. Dr Koo is an ascending star in stem cell research and a world leading researcher in the experimental dissection of human stomach development –  all generated from stem cells.

ASMR Peter Doherty Leading Lights Award.  This year ASMR will launch a new award aimed at recognising the outstanding contributions of Australian mid-career researchers.

The Networking and Mentoring Breakfast.  A unique opportunity for students in particular to share their concerns and ask questions of experienced mentors.

 

 

 

 

 
 
 
 
 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 2.7 SEPTEMBER 2017

Research Roundup:

September  2017

.
 

Welcome Message

We are pleased to announce that the TSANZ Awards for Research and Career Development are now open!

The TSANZ awards that you all know well are now open. We would like to highlight two of these awards which have been revised to open up the eligibility and use of these important funds. The TSANZ Peter Phelan Research Award is no longer limited to travel and funding may now be used to support any research venture in paediatric research, including but not limited to; training, travel, equipment, methodology, analysis, technical consult and/or consumables. Furthermore, the Maurice Blackburn Grant-in-Aid for Occupational Lung Disease is no longer bound to asbestos-related research and is open for applications for research into any occupational lung disease. We also have a brand new award – we are excited to offer for the first time the TSANZ/LFA CSL Behring Research Award for Alpha-1 anti-trypsin deficiency

Remember too, abstract-linked awards will close on 13 October as submissions for the TSANZSRS ASM 2018 close. Apply now for some of the many abstract-linked awards and take the opportunity to present your work to our full membership by entering the Ann Woolcock New Investigator competition.

The full list of awards and more information on these can be found in the Open Awards section of this newsletter and on the TSANZ Awards web page.

Like many of our members, we have recently returned from the European Respiratory Society Congress where an overwhelming amount of scientific and clinical advances, discussions and debates were had over five days. The abstracts for most sessions can be found here and the limbic have provided us with some articles below highlighting key messages.

Enjoy the September edition of your research roundup.

Prof Phil Hansbro

Prof Sandra Hodge

Co-Chairs, Research Sub-Committee

The following articles will take you to thelimbic.com

ERS Review

We need to radically rethink asthma

Quadruple ICS a game changer for severe asthma

Revised GOLD criteria under scrutiny

CT scans help guide emphysema treatment

Mixed results for biologic in eosinophilic COPD

Vaping: Smokers also vape, respiratory irritants rife

The Holy Grail

How the heart matters in COPD. In this week’s holy grail Rain Shafuddin from New Zealand tells us how his work is contributing to the changing paradigm of cardiac dysfunction in COPD patients.  Read More.

Top articles from the limbic

Stormy debate over thunderstorm asthma. Clinicians are debating whether to suggest seasonal preventative corticosteroids for people who have mild asthma plus hay fever in new guidelines for thunderstorm asthma prevention in Victoria. Read More.

Oxygen in ILD is complicated. The stigma associated with oxygen use, its complexity of use and an ‘evidence-free zone’ conspire against achieving optimal management of patients with interstitial lung disease. Read More. 

Fan-tastic intervention for chronic breathlessness. Patients with breathlessness are using hand-held fans to delay the use of oxygen therapy and inhaled beta-agonists. Read More.

ICS/LABA combination dominates Australian asthma treatment. Australians using an inhaled corticosteroid for asthma are almost twice as likely as New Zealanders to take it in combination with a long-acting beta agonist but disease control is equally poor in both countries, new research has shown. Read More.

COPD and asthma contribute to global burden of disease.  COPD caused 3.2 million deaths worldwide in 2015 – up almost 12% from 1990 as population growth and ageing outweighed any downward trend in age-standardised death rates. Read More.

Open Awards

Thoracic Society Awards

Abstract-linked awards now open

To apply for an abstract-linked award, you must complete the application coversheet using the upload functionality in the online abstract submission portal

Ann Woolcock New Investigator Award

Boehringer Ingelheim COPD Travel Award

Janet Elder International Travel Award

Japanese Respiratory Society (JRS) Early Career Development

TSANZ Travel Grants to 2018 ASM

For more information visit http://www.tsanzsrs2018.com/abstracts/tsanz-awards-criteria/

Abstracts close 13 October 2017

 

TSANZ Research and Career Development Awards now open

TSANZ Peter Phelan Research Award

TSANZ Indigenous Respiratory Nursing Award

TSANZ / National Asthma Council Australia – Asthma and Airways Fellowship

Boeringher Ingelheim COPD Research Award

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health

TSANZ/LFA CSL Behring Research Award for Alpha-1 anti-trypsin deficiency 

Awards close 13 November 2017

For more information visit https://www.thoracic.org.au/researchawards/tsanz-awards

More opening coming soon!

 

Lung Foundation Australia Awards

Lung Foundation Australia / Cochrane Airways Australia Scholarship 2018

Lung Foundation Australia and Cochrane Airways Australia invite applications for the Lung Foundation Australia/Cochrane Airways Australia Scholarship 2018 valued at $2,500. This scholarship is intended to assist with the completion, update and/or presentation of a Systematic Review. Cochrane Review Scholarships have been awarded on an annual basis since 2001, and have been highly productive.

A Cochrane review is an ideal topic for an advanced trainee in any health profession, or when initiating a PhD program, as most reviews can be completed within a year. Completed reviews are published on the Cochrane Database of Systematic Reviews (Impact Factor 6.124 effective July 2016) and indexed in Medline. Conducting a review provides experience in critical appraisal of the literature, and other aspects of Evidence-Based Medicine.

MORE INFORMATION

Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards deadline extended to midnight 01 October 17

Lung Foundation Australia and A Menarini Australia Pty Ltd are offering two (2) Travel Grants of up to $1,500 for national conferences to key health professionals and researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

The Travel Grants will be allocated across the following conference:

  • APSR – Asian Pacific Society of Respirology Congress, 23 – 26 November 2017, Sydney, Australia. Applications close midnight 01 October 17.

Extra weighting will apply to those who have submitted an accepted Abstract (oral or poster) for the particular conference being applied for. Click here for more information.

Please note: Existing travel payments can be reimbursed for the successful applicants

Apply now

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

TSANZ Awards by Nomination

Nominations for the 2018 year have opened!

The following prestigious awards are presented annually to TSANZ members as an acknowledgment of the recipients’ outstanding and sustained contributions to respiratory health via advocacy and/or clinical practice, research and education. The nomination deadline for all the below awards is midnight AEDT Sunday 15 October 2017. All valid award nominations are submitted to the TSANZ Board for review and selection. 

All of TSANZ’s Awards by Nomination are open to all financial members of the TSANZ. Nominees must be a financial member in the year they are nominated (2017) as well as the year the medal is awarded (2018). All nominations require support from two TSANZ members who are financial in the year the nomination is submitted (2017).

The Society Medal

The Society Medal was conceived as an acknowledgment of excellence in fields other than research, i.e. for the advancement of the practice of thoracic medicine in its widest sense by outstanding teaching or advocacy. Apply Now!

The Research Medal

The Research Medal is awarded in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in their field of research. Apply Now!

The 50th Anniversary Medal for Education & Training

The 50th Anniversary Medal for Education & Training was introduced in 2011 to mark the Society’s 50th Anniversary. The 50th Anniversary Medal is awarded in recognition of outstanding contributions to respiratory education and training in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in education and training.

This might take the form of formal and informal teaching within a university, hospital or other health care setting; curriculum development at an undergraduate or postgraduate level; using research to enhance the efficacy of educational activities; career mentoring of junior members of the Society; integration of teaching into clinical practice; or advocacy on behalf of medical education as applied to respiratory medicine. Apply Now!

Members from all disciplines and all branches of the Society are strongly encouraged to nominate a colleague for one of TSANZ’s Awards by Nomination!

Assistance

If you have any queries about submitting a nomination for any of the above awards, please contact the TSANZ office on + 61 2 9222 6200 between 9:00am and 5:00pm AEST or email TSANZoffice@thoracic.org

Fellow of the Thoracic Society

Nominations for the 2018 year have opened!

In 2012 the TSANZ Board created the official honour, Fellow of the Thoracic Society of Australia & New Zealand, to recognise TSANZ members with exceptional expertise and experience in respiratory medicine, research or health service and to acknowledge major contributions to the advancement of respiratory health in Australia or New Zealand.

All valid applications will be submitted to the TSANZ Professional Standards Sub-Committee (PSS) for review, before final ratification by the TSANZ Board.

Criteria

TSANZ Members considering applying for Fellowship of the TSANZ will need to meet the following criteria:

  1. A continuous financial member of TSANZ for five consecutive years in Australia and/or New Zealand as well as a minimum of ten years post-specialist qualification
  2. Contribution to advocacy and/or policy development
  3. Service within the community
  4. Distinguished leadership
  5. Contribution to research
  6. Contribution to teaching or training
  7. International recognition in his or her discipline.

Please Note: Applicants need to demonstrate exceptional contributions to 5 out of the 7 criteria listed above. For the remaining 2 criteria, the applicant must demonstrate a proven track record.

Application

If you would like to submit an application for TSANZ fellowship, or nominate a colleague, please CLICK HERE to download the application form.

Awarding of TSANZ Fellowship

  1. All successful TSANZ Fellow awardees will be announced at the Annual General Meeting at the Adelaide Annual Scientific Meeting in March next year.
  2. Following announcement, successful applicants for TSANZ Fellowship may employ the post nominal FThorSoc whilst remaining a financial member of the TSANZ.
  3. All FThorSoc recipients will receive a certificate, following the AGM.

 

TSANZ Fellows

The following members are recognised as having achieved TSANZ Fellow Status:

2017

  • Abe Rubinfeld
  • David Fielding
  • Hubertus Jersmann
  • Matthew Peters
  • Peter Wark
  • Phil Hansbro
  • Scott Bell
  • Vanessa McDonald

2016

  • Christine McDonald
  • Kwun Fong

2015

  • Adam Jaffe
  • Anne Chang
  • Graham Hall
  • Haydn Walters
  • Ian Yang
  • Jennifer Alison
  • John Upham
  • Peter Gibson
  • Peter Middleton
  • Robyn O’Hehir

2014

  • Anthony Breslin AM
  • Christine Jenkins
  • David Langton
  • David Serisier
  • Gary Anderson
  • Graham Simpson
  • Jo Douglass
  • John Armstrong
  • Martin Phillips
  • Paul Reynolds
  • Peter Frith
  • Peter Sly
  • Peter van Asperen
  • Philip Thompson

2013

  • Robert Edwards

Grant Bulletin

This grant bulletin contains direct-to-researcher grants and awards due between October and December, 2017:

World Cancer Research Fund International – closes 06/10/17
To fund research studies exploring the link between diet, nutrition, body composition, physical activity, and cancer prevention and survival. There are 2 types of grants: Investigator Initiated Grants for Principal Investigators; and Pilot Grants to be used as start-up funds for pilot research. Two main themes: identifying the mechanisms that underpin the effects of diet, nutrition and physical activity on cancer; addressing the host factors that influence an individual’s susceptibility to cancer development or progression.

The Bonser Family Research Grant and Mi-tec Publishing Medical Research Grant – closes 21/10/17
Cancer Council Tasmania calling for research relating to the reduction of the incidence and impact of cancer on individuals and the community. It includes every aspect of care, from prevention and early detection that leads to a better outcome, treatment and supportive care. The priority area is cancer control.

2017 VicHealth Innovation Research Grant – EOI closing date 26/10/17
VicHealth is calling for applications from researchers to undertake a two-year innovative research project that has the potential to generate large health gains for Victorian population groups. Projects must address one of VicHealth’s research priorities: promoting healthy eating; encouraging regular physical activity; preventing tobacco use; preventing harm from alcohol; improving mental wellbeing.

Bill & Melinda Gates Foundation Grand Challenges Explorations Round 20 – closes 08/11/17
Early-stage innovative research projects from a range of disciplines and regions. The challenges for Round 20 are: Healthy Minds for Adolescent Mothers: Achieving Healthy Outcomes for the Family; Innovations for Integrated Diagnostics Systems; Novel Approaches for Improving Timeliness of Routine Immunisation Birthdose and Healthcare Worker Skill in Low-Resource Settings.

Integra Underground Community Investment – closes 01/12/17
Funding is provided for the following focus areas: Capacity Building, including education/training, enterprise development, and economic diversification; Health; Environment.

Pro Bono Australia – Impact 25 Awards (2017) – closes 01/12/17
Award to name the year’s most influential people who have made a significant and positive impact. Nominees should embody the principles of integrity, initiative, foresight, and collaboration.

Australian Respiratory Council Harry Windsor Research Grants Scheme – closes 07/12/17
For projects which address research in tuberculosis, respiratory diseases due to other infections, or respiratory diseases related to tobacco use. Within these categories, projects examining TB/HIV, community issues or the health of disadvantaged groups that relate to the work that the ARC undertakes within Australia and the Pacific Region are particularly encouraged. The proposals can encompass clinical research, public health research or basic scientific research. Grants are available for projects submitted to the National Health and Medical Research Council (NHMRC) which are considered fundable but which do not reach the cut-off mark for funding in any one year.

Perpetual Trustees 2018 IMPACT Philanthropy Application Program – closes 08/12/17
Perpetual distributes to all sectors including social welfare, health, medical research, conservation and environment, education, and arts and culture. As is consistent with Perpetual’s IMPACT Philanthropy Application Program process, an organisation’s submission will be assessed against Leadership, Capability, Strategy and Outcomes. Further 2018 information will be released later in 2017.

Allen Foundation Grants (2018) – closes 31/12/17
Priorities are: to fund relevant nutritional research; to support programs for the education and training of mothers during pregnancy and after the birth of their children; to assist in the training of persons to work as educators and demonstrators of good nutritional practices; to encourage the dissemination of information regarding healthful nutritional practices and habits; in limited situations to make grants to help solve immediate emergency hunger and malnutrition problems.

Rolling Grants

Auswide Community Grants Scheme –  grants under $5 000 close 30/09/17, grants over $10 000 close 21/10/17, grants over$ 5 000 close 01/12/17.
Supports local activities, organisations, events and projects covering a wide range of sporting, cultural and community interests and endeavours. Includes community services, events and celebrations, buildings, public spaces and facilities, research, and organisational development.

John Templeton Foundation
Interest areas are: science and the big questions; character virtue development; freedom and free enterprise; exceptional cognitive talent and genius; genetics; voluntary family planning.

Boehringer Ingelheim Fonds Travel Grants
Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

Baxalta Bioscience Grants – Medical Education & Fellowship Grants
Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

Coopers Brewery Foundation – current round closes 01/08/2017
Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

The Balnaves Foundation
The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

allport bequest – closes 30/06 and 31/12 yearly
Must benefit citizens of Hobart. Organisation must be charitable or the project must be for charitable purposes.

Respirology

Congratulations and thank you to our members involved in the publication of the new TSANZ/LFA IPF position papers. 

Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

Helen E. Jo, Lauren K. Troy, Gregory Keir, Daniel C. Chambers, Anne Holland, Nicole Goh, Margaret Wilsher, Sally de Boer, Yuben Moodley, Christopher Grainge, Helen Whitford, Sally Chapman, Paul N. Reynolds, Ian Glaspole, David Beatson, Leonie Jones, Peter Hopkins, Tamera J. Corte

DOI: 10.1111/resp.13146

The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

Jyotika D. Prasad, Annabelle Mahar, Jane Bleasel, Samantha J. Ellis, Daniel C. Chambers, Fiona Lake, Peter M.A. Hopkins, Tamera J. Corte, Heather Allan, Ian N. Glaspole

DOI: 10.1111/resp.13163

 

Editor’s Choice – Respirology Issue 22.7

Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis

Francesco Bonella, Xiaoping Long, Xuan He, Shinichiro Ohshimo, Matthias Griese, Josune Guzman and Ulrich Costabel

DOI: 10.1111/resp.13082

 

Research team members from Germany and Japan. From left to right: Francesco Bonella, Ulrich Costabel and Shinichiro Ohshimo

 

Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort

Matthew R. Lammi, Lesley A. Saketkoo, Jessica K. Gordon, Paula Lauto, Karen Fagan, Virginia D. Steen and on behalf of the PHAROS Investigators

DOI: 10.1111/resp.13067

 

‘River Spirit’ by glass artist Ray King, displayed in the lobby of University Medical Center New Orleans

 

APSR Fukuchi Award for Best Original Research Paper published in Respirology

Randomized controlled trial of the effect of regular paracetamol on influenza infection
Sarah Jefferies, Irene Braithwaite, Steven Walker, Mark Weatherall, Lance Jennings, Michelle Luck, Kevin Barrett, Robert Siebers, Timothy Blackmore, Richard Beasley, Kyle Perrin, On behalf of the Pi Study Group

DOI: 10.1111/resp.12685

The paper was shortlisted, from all 2016 Respirology research papers, by an international expert panel comprising of Prof Antonio Anzueto (University of Texas, San Antonio, USA), Prof John Mastronarde (Ohio State University, Columbus, USA), Prof Chunxue Bai (APSR Research Committee, Shanghai, China), Prof Albert Li (Prince of Wales Hospital, Hong Kong) and Prof Christina Spengler (ETH Zurich, Switzerland), chaired by Prof Michael Niederman (Weill Cornell Medical College, NY, USA).The award will be formally presented at the next APSR Congress in Sydney, Australia in November 2017.

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma. This is the first round of a multi-national Delphi process to reach a consensus and there will be follow-up questions based on the answers we receive from round one (with likely three rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Research Masters degree by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=l6M2m5m3

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai 
JamesMichael.Ramsahai@uon.edu.au

 

Case Management of Venous thromboembolism

Many thanks for your time in completing this short survey, which should take no longer than 5 minutes. At St. John of God, we are exploring the management of VTE in patients with or without malignancy and in the perioperative setting.

We appreciate there are a large number of guidelines, many of which can be contradictory in their recommendation. Irrespective of this, we would greatly value your feedback on how you would manage the following cases, recognising that several answers may be appropriate.

This survey consists of 4 short cases which will cover a range of clinical scenarios with regards the management of VTE in the immediate post-operative and preoperative period, as well as the management of VTE in the setting of suspected and confirmed solid organ malignancy.

https://www.surveymonkey.com/r/IVCFilter

All results are completely anonymised and your participation is greatly appreciated.

Kind regards,

Prof Eli Gabbay egabbay@respiratorywest.com.au
Dr Philip Craven

 

Australian Society for Medical Research National Scientific Conference

Held in Sydney, at the Charles Perkins Centre, from November 14th to 15th, 2017 the NSC has an exciting new design all packed up in a shorter format.

In these highly competitive times, the NSC 2017 will fulfil an important yet unmet need for early to mid career health and medical researchers.

Entitled “Science and Survival – equipping you with the tools to further your research career” the aims of the  conference are:

  • To empower and inspire our present and future scientific leaders.
  • To provide a springboard for early to mid-career researchers to showcase their research.
  • To promote scientific excellence, collaboration and transdisciplinary research.
  • To upskill in grantsmanship and understand the promotion process.
How are we going to achieve this?

We are very excited about the new format of NSC 2017 with both scientific presentations and visionary professional development workshops.

Conference highlights

Mock GRP session with all the elements of a GRP and the perspective of a narrator.

Inside the scientist studio – Norman Swan  interviews Nobel Prize Winner Professor Peter Doherty.

Politics of promotion to provide invaluable insights into the intricate and necessary journey to Associate Professorship.

The Edwards Orator is Distinguished Professor Jagadish Chennupati from ANU. A stellar transdisciplinary researcher and a nanotechnology pioneer. ­­­He is also a charismatic leader and mentor who will inspire our participants.

Dr Bon-Kyoung Koo from the University of Cambridge will deliver the Firkin Oration. Dr Koo is an ascending star in stem cell research and a world leading researcher in the experimental dissection of human stomach development –  all generated from stem cells.

ASMR Peter Doherty Leading Lights Award.  This year ASMR will launch a new award aimed at recognising the outstanding contributions of Australian mid-career researchers.

The Networking and Mentoring Breakfast.  A unique opportunity for students in particular to share their concerns and ask questions of experienced mentors.

 

 

 

 
 
 
 
 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 1.07 SEPTEMBER 2016

Research Roundup:

September 2016

.
 

Welcome Message

This Research Roundup comes off the back of the ERS Congress; the largest respiratory conference ever! This event saw a concentration of more than 22,000 respiratory researchers, with even more virtual delegates attending through the live congress streaming. Despite the paucity of funding for respiratory research there is still a vibrant community. For respiratory professionals who could not attend the congress in person and would like catch up on particular sessions, on demand viewing of the ERS is still available via the TSANZ website. 

TSANZ is currently negotiating an en bloc membership arrangement with the ERS.More details will follow on this and we look forward to making an announcement shortly.

More awards are now open for application. The Maurice Blackburn Grant-in-Aid and the suite of Lung Foundation Australia awards are now available.

The TSANZ Awards by Nomination are a special class of award. The TSANZ Board would like to encourage you to please consider nominating a leader in the field Respiratory Medicine who is deserving of recognition through one of the these awards:

The Research Medal

Awarded in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand. 

The Society Medal

Awarded  as an acknowledgment of excellence in fields other than research, i.e. teaching or advocacy. 

The 50th Anniversary Medal for Education and Training

Awarded in recognition of outstanding contributions to respiratory education and training in New Zealand or Australia. The award recognises an individual who has demonstrated sustained excellence in education and training.

Please see our web site for more information.

Also currently open is the annual call for nominations for Fellow status. Members from all professions who demonstrate exceptional contribution to the field of respiratory health in Australia or New Zealand can apply to be a Fellow of TSANZ. If the Fellow status is approved, the member will be able to use the post nominal FThorSoc and will be able to continue to do so whilst a financial member of TSANZ.

The main aims of the Fellow status are:

  1. To recognise expertise and experience in respiratory medicine and/or research and/or respiratory health service provision.

  2. To acknowledge a major contribution and commitment to advancing respiratory health in Australia and/ or New Zealand.

Finally, and I know this is not research-related, it is vitally important that TSANZ members respond to the report of the Clinical Committee on Thoracic Medicine which was released on Friday – more information below.

Enjoy your September Research Roundup,

Prof Phil Hansbro

Chair, Research Sub-Committee

The following articles will take you to thelimbic.com

Potential role for vitamin D in asthma management. A Cochrane review has provided more robust evidence that adding vitamin D supplements to routine asthma management plans may benefit patients. However more research is required to confirm optimal dosing and the likely benefit in various patient sub-groups, says co-author Dr Megan Jensen. Read More.

What if asthma is actually a rash? Australian researchers are taking a novel approach to treating asthma as a rash, rather than a respiratory disease. We caught up with Professor Bruce Thompson about why this could change the way we think about asthma. Read More.

TSANZ adds voice to stem cell concerns. Australian thoracic specialists have added their collective voice to an international position statement condemning the use of “unproven stem cell interventions for lung diseases” – as the groundswell of multi-disciplinary opposition to the practice grows. Read More. 

Embrace the new equations. A position statement on reference values for spirometry and their use in test interpretation will encourage more clinicians to embrace the new equations, experts say. Read More.

A definition for ACOS. A push to have ACOS declared as disease in its own right is gathering momentum with the release of a draft operational definition by Australian authors. Read More. 

New mechanism of infection for TB. Mycrobacterium tuberculosis infects the body through a previously unknown route of entry, new research suggests. Read More.

Report of the Clinical Committee on Thoracic Medicine

On Friday last week, the Government released the report of the Clinical Committee on Thoracic Medicine. TSANZ will respond to this an an organisation, but also invites each one of you to respond as an individual, and to send us your feedback at info@thoracic.org.au 

The online consultation is open from Friday 9 September until Friday 7 October 2016: MBS Review Task Force Consultation.

Further information on the consultation can be found at the Department of Health Website

Please note on the 6 September 2016, the MBS Review Task Force released an Interim Report to the Minister for Health.

Research Project and Survey Requests

Barriers and facilitators to optimal use of acute oxygen therapy in adults

Dear colleagues,

Our research  team is conducting a study to investigate the  barriers, facilitators and attitudes of health care professionals towards the prescription and delivery of oxygen therapy in the acute care setting. We hope that the results from this study will provide information that will be used to inform and facilitate the translation of evidence based guidelines into clinical practice.

As a clinician who delivers care to patients who use oxygen therapy, we understand that your views and opinions are important. You are invited to participate in this voluntary online survey. It is expected that this should take no longer than 15 minutes. There are no correct or incorrect responses, this survey is designed to explore your opinions regarding acute oxygen therapy.

This study has been granted ethics approval by Hunter New England Human Research Ethics Committee  (Approval number: 16/04/20/5.03) and the University of Newcastle Human Research Ethics Committee (Reference Number: H-2016-0222). For further information you can view the participant information HERE

There are no anticipated risks to you for taking part in this survey. Information that you provide will be anonymous and remain confidential. Only those directly involved in this research have access to any answers that you provide. Participation in the survey implies consent and can be completed by clicking  the  OXYGEN SURVEY LINK HERE

Please feel free to contact us directly if you have any questions regarding this research.

We thank you in advance for participating and ask you to consider forwarding this survey to other colleagues, who also deliver care to patients with oxygen therapy.

Kind Regards

Professor Vanessa McDonald
Professor Peter Wark
Joyce Cousins (PhD Scholar)
Contact: joyce.cousins@uon.edu.au

Inhaled Liposomal Amikacin for treatment resistant MAC infection – a randomised control trial enrolling now.

Dear TSANZ members,
There is currently an industry sponsored RCT of Nebulised Liposomal Amikacin for pulmonary MAC infection which has failed six months of standard therapy or relapsed after treatment. This is the first RCT of a novel compound for NTM infection. Inclusion and exclusion criteria are in the link below.

https://clinicaltrials.gov/ct2/show/NCT02344004?term=LAI&rank=3

The CONVERT STUDY is an international, multi-centre study and there are a number of study sites in Australia and New Zealand. The study sponsor is prepared to pay for travel and accommodation expenses for people in regional areas to travel to study sites.
If you wish to discuss possible patients for screening and enrolment, I can be contacted via email at andrew.burke@health.qld.gov.au, and I can direct you to your nearest study site.

Dr Andrew Burke
Thoracic and Infectious Diseases Physician
The Prince Charles Hospital, Brisbane
(study PI, no conflicts)

Perioperative care of patients with OSA: A survey of beliefs and management approaches amongst Australian clinicians

Obstructive sleep apnoea (OSA) has a rising prevalence in the general population and in those presenting for surgery. It is an established risk factor for increased incidence of peri-operative and post-operative complications. There are currently no consensus-based recommendations on management of these patients in Australia. We wish to conduct a survey of specialties involved in the care of these patients to examine current practice and beliefs in the perioperative management of OSA. The results will be reviewed by the Respiratory and Sleep Department at St Vincent’s Hospital Melbourne, to identify  current trends in practice, and to ultimately guide towards a consensus approach in this field.

The survey link is: https://www.surveymonkey.com/r/perioposa

Dr Chong Weng Ong | Respiratory and Sleep Consultant | St Vincent’s Hospital Melbourne

Joy Sha | Respiratory and Sleep Registrar | St Vincent’s Hospital Melbourne

GP COPD Survey for Primary Care SIG

Dear Colleague

Our research team is conducting a survey to understand how General Practitioners (GPs) and GP registrars approach symptom management and palliative care, when caring for patients with severe Chronic Obstructive Pulmonary Disease (COPD). From the results of this study we hope to develop educational resources to assist GPs when caring for this patient group.

We invite you to take part in a voluntary online survey, which will take 5-10 minutes to complete.  There are no right or wrong answers to the questions in this survey.

www.surveymonkey.com/r/GPbreathlessnessCOPD

Participant Information letter

Kind regards

Dr John Politis | Basic Physician Trainee | Department of Respiratory & Sleep Medicine  The Royal Melbourne Hospital – City Campus | Level 1 Centre for Medical Research Building | Melbourne | Tel: +61 3 9342 7708

Dr Natasha Smallwood | Respiratory Physician | Department of Respiratory & Sleep Medicine  The Royal Melbourne Hospital – City Campus | Level 1 Centre for Medical Research Building | Melbourne | Tel: +61 3 9342 7708

A/Prof Louis Irving | Director of Respiratory & Sleep Medicine  | The Royal Melbourne Hospital | Melbourne

A/Prof Brian Le | Director of Palliative & Supportive Care | The Royal Melbourne Hospital | Melbourne

COPD survey invitation for Physio, Primary Care and Respiratory Nurse SIG

Dear Colleague

Our research team is conducting a survey to understand physiotherapist’s, occupational therapist’s, nurse’s, social worker’s and other allied health professionals’ knowledge and practice behaviours regarding advance care planning in patients with COPD. From the results of this study we hope to develop educational resources to assist health professionals when caring for this patient group.

We invite to participate in a survey, that should take only 10-15 minutes to complete. Several disciplines are represented in the overall survey, however you will be directed to only those questions relevant to your discipline.

Ethics approval has been granted for this study from the University of Sydney. All responses will be anonymous and confidential. No personal information that could identify you is being collected and your email address will not be linked to your survey response. Your consent to participate in this study is implied by completing the survey.

Further information about this research study is provided in the enclosed document [DOWNLOAD]. If you have any questions regarding this research, please do not hesitate to contact Dr Rebecca Disler directly. Thank you in advance for participating.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser: https://www.surveymonkey.com/r/ACPHealthProf

Kind regards

Dr Rebecca Disler | Senior Lecturer in Chronic Disease | The University of Sydney
Email:
 rebecca.disler@sydney.edu.au  | Tel: 0406 876 587

Dr Natasha Smallwood | Respiratory Physician Department of Respiratory Medicine | The Royal Melbourne Hospital

A/Prof Louis Irving | Respiratory Physician Department of Respiratory Medicine | The Royal Melbourne Hospital
Prof David Currow | Palliative Care Physician Flinders University | Adelaide

STUDENT DECLARATION  Yuxiu Cui will be analysing the study results as the basis for her degree of Bachelor of Advanced Nursing (Honours) at The University of Sydney. This will take place under the supervision of Dr Rebecca Disler.

 
 
 
 

 

 

 

 
 
 
 
 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 4.05 JULY 2019

Research Roundup:

July 2019

.
 

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. The wheels have officially begun turning for our 2020 TSANZ ASM, which means a wide range of opportunities to submit abstracts and will be opening on 12 July! Please visit our TSANZSRS2020 website for more details about abstracts & TSANZ Travel Awards once the submission portal is live, and pay close attention to the closing dates.
For our registered nurses, don’t forget about the TSANZ Indigenous Respiratory Nursing Awards, which will help support the cost of attendance to the TSANZ ASM for those with indigenous heritage, or working with indigenous communities in respiratory health.

We have a few new Lung Foundation Australia awards opening this month, so see below for details. Applications are still open for LFA/A Menarini travel grants for ERS and APSR – if you are interested in attending be sure to send in your submissions before the deadline. We have also extended the date for the Brian Eaton IPF award.
If you are planning on attending the TSANZ New Zealand Annual Scientific Meeting, we still have travel grant applications open until 15 July so click here to apply now.

We would also like to bring to your attention the Bupa 2019 Emerging Health Researcher Awardnominations are open on their website. This award is designed for Early Career Researchers and the recipient will receive a prize of $25,000 to put towards further research. Selected Finalists and Highly Commended nominations will also be recognised.
icare also have opened their Dust Diseases Grant program to applicants, which closes 2 August. Please scroll down for more information on both.

We hope you enjoy the July edition of your Research Roundup!

 

Tanya Buchanan
(standing in for Sandra Hodge earning a well-earned break!)
CEO, The Thoracic Society of Australia and New Zealand

Open Awards

Thoracic Society Awards

TSANZ NZ ASM Travel Grants 2019 – closes 15th July 2019

TSANZ ASM 2020 abstract-linked Awards – closing 11 October 2019
(N.B. the submission portal will become live on July 12)

TSANZ Indigenous Respiratory Nursing Award – closes 30th October 2019

Lung Foundation Awards

LFA / Brian Eaton IPF PhD Scholarship – EXTENDED until 14 July 2019 

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards 

Travel application deadlines

ERS: 31st July 2019 (5pm AEST)

APSR: 13th September 2019 (5pm AEST)

N.B. The following awards will open 14 July

BI / COPD Research Fellowship – closes 25 August 2019

Lung Foundation Australia / Lizotte Family Research Award for IPF Research – closes 25 August 2019

LFA / Ludwig Engel Grant-In-Aid for Physiological Research – closes 25 August 2019

Ivan Cash Grant-In-Aid for IPF Research – closes 25 August 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

iCare Dust Diseases Grant Program

For all the application details, please visit https://www.icare.nsw.gov.au/injured-or-ill-people/work-related-dust-disease/research-and-funding/#gref.
If you have any questions or would like to know more about the program please contact: ddcgrants@icare.nsw.gov.au 

Bupa Health Foundation Emerging Health Researcher Award

The Bupa Health Foundation is seeking nominations for its 2019 Emerging Health Researcher Award.  

Nominations close on Monday 15th July 2019 (9AM AEST).

Award criteria and the nomination form can be found at https://www.bupa.com.au/about-us/bupa-health-foundation.

Should you have any queries, please contact Alana Fisher, Operations Manager, Bupa Health Foundation at foundation@bupa.com.au

_______________________________________________________________________________

Respirology – Editor’s Choice 

Respirology Issue 24.7 July 2019

Clinical usefulness of routine AFB culture and MTB PCR of EBUS‐TBNA needle rinse fluid

Ryoung-Eun Ko, Byeong-Ho Jeong, Hae Ri Chon, Hee Jae Huh, Joungho Han, Hyun Lee, Kyungjong Lee, Hojoong Kim, O. Jung Kwon, Sang-Won Um

 

Researchers from the Division of Pulmonary and Critical Care Medicine at the Samsung Medical Center in Seoul, South Korea. From left to right: Byoung-Ho Jeong, Sang-Won Um, and Ryoung-Eun Ko

DOI: 10.1111/resp.13488

 

Changes in physical activity during hospital admission for chronic respiratory disease

Mark W. Orme, Theresa C. Harvey-Dunstan, Ismet Boral, Emma J.L. Chaplin, S. Fayyaz Hussain, Mike D.L. Morgan, Michael C. Steiner, Sally J. Singh, Neil J. Greening

 

A single day of physical activity monitoring

DOI: 10.1111/resp.13513

Research Project and Survey Requests

 

What is “suspected” lung cancer?

Lung cancer is the leading cause of cancer-related mortality and morbidity in Australia. The Cancer Council’s Optimal Care Pathway suggests that patients with suspected lung cancer on CT scan be seen by a specialist within two weeks. But what exactly is “suspected” lung cancer? Does that 5mm lung nodule found incidentally on CT coronary angiogram need urgent specialist attention?

St John of God Healthcare doctors and Curtin University researchers are inviting respiratory physicians to help us define “suspected” lung cancer. We need you to review 10 short case scenarios and tell us if each of the patients should be seen by a specialist within two weeks.

To participate, click here.

You have been anonymously invited to participate because the Thoracic Society of Australia and New Zealand identifies you as a member. Consent is implied by your voluntary participation. This research study has been reviewed and given approval from the Curtin University and St John of God Healthcare Human Research Ethics Committees.
If you have questions or comments, you can contact the Principle Investigator on david.manners@sjog.org.au, the Curtin University HREC on hrec@curtin.edu.au or the SJOG Healthcare HREC on ethics@sjog.org.au.

 

Survey of Attitudes of Australian Specialists to Lung Cancer Screening with Low Dose Computed Tomography

To Members of the Thoracic Society of Australia and New Zealand,

Lung cancer screening with low dose computed tomography has been implemented overseas however is still a debated topic within Australia. We are conducting a survey of Australian specialists and their knowledge and attitudes towards lung cancer screening and perceived barriers to the implementation of lung cancer screening with low dose computed tomography within Australia.

The anonymous survey is available online using the SurveyMonkey survey tool and takes approximately 7 minutes to complete.  It can be accessed via the following link.  https://www.surveymonkey.com/r/AttitudesToLDCT

Please don’t hesitate to contact us if you require any further information.  We attach our study protocol and copy of HREC approval (The Prince Charles Hospital Human Research and Ethics Committee LNR/2018/QPCH/44970).

Thank you for your kind support.

Yours truly

Rachel McLellan, Advanced RACP Trainee
Kwun Fong
Henry Marshall
Rayleen Bowman
Ian Yang

University of Queensland Thoracic Research Centre at The Prince Charles Hospital
Metro North Hospital and Health Service | Queensland Government
Rode Road, Chermside, Brisbane QLD 4032, AUSTRALIA
t. 61 7 [31394000] e. ILST@health.qld.gov.au | www.health.qld.gov.au

 

 

New survey about Victorian doctors’ end-of-life decision-making

Victorian doctors in specialties likely to be involved in end-of-life decisions are being surveyed about their decision-making practices involving adult patients. Researchers from the NHMRC-funded Centre of Research Excellence in End-of-Life Care are conducting a study to determine what sort of end-of-life decisions are being made by doctors, how often these decisions occur and for what sort of patients.

At present, there are no up-to-date, representative Australian data describing the frequency and nature of medical end-of-life decisions involving adults, and the characteristics of patients about whom such decisions are made. The research aims to provide an evidence base to understand current medical practice in Victoria including the extent to which palliative care is provided to patients at the end of life. Findings from this research will also inform improvements in the quality of end-of-life care.

A sample of Victorian doctors will be contacted in April and May by the AMA’s Australia Medical Publishing Company (AMPCo) to invite them to complete a survey.  The survey can be completed in hard copy or online.  Participating doctors who complete their survey before 16 May will go into the draw for one of three prizes to the value $100, in fine wine, or a donation to a registered charity of your choice.

If you have any queries about this research, please feel free to contact Dr Rachel Feeney[rachel.feeney@qut.edu.au]. The research team is grateful for the time and insight of the doctors who support this research by completing this survey.

 

 

Genomic medicine here to stay? Have your say.

Are you a medical specialist in Australia?

If so, tell us your thoughts about genomic medicine
practice and continuing medical education!

We need to hear from non-genetic medical specialists
who work clinically in Australia.

We want to know about past, present and future aspects
of genetics and health, including genomics in healthcare.

It doesn’t matter how much you know about this,
or whether you incorporate genomics into your practice or not;
your opinions, views and experiences are valuable to us.

You will help shape future workforce practices and
continuing education and training programs

Click here to complete the anonymous 15-minute survey.
Please distribute this link to your networks

Please note there are separate studies for clinical geneticists, oncologists, pathologists, radiologists and general practitioners, who will be contacted directly.

This survey is an activity of the Workforce Development Program of the NH&MRC-funded
Australian Genomics Health Alliance. If you have any queries, please contact Dr Amy Nisselle, Specialist Project Officer, Australian Genomics Health Alliance (amy.nisselle@mcri.edu.au or 03 9936 6340).

This survey has HREC approval, The University of Melbourne (1646785.8).

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

VOLUME 5.04 – JUNE 2020

VOLUME 3.07 OCTOBER 2018

Research Roundup:

October 2018

.
 

Welcome Message

Welcome to October – a busy month for awards as the first wave of awards close and the second wave of awards open. We are pleased to announce that the Boehringer Ingelheim COPD Research Award is now open, and the Boehringer Ingelheim Australia COPD Travel Award and Boehringer Ingelheim New Zealand COPD Travel Award have been added to the TSANZSRS2019 abstract submission portal.

Don’t forget that Abstract-linked awards are closing soon! (this Friday!) Apply now for some of the many abstract-linked awards and, for early career researchers, take the opportunity to present your work to our full membership by entering the Ann Woolcock New Investigator competition.

The full list of awards can be found in the Open Awards section in this newsletter and on the TSANZ Awards web page.

Lastly, please support the research of TSANZ members and supporters by contributing to the surveys at the end of this newsletter.

Enjoy the October edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

Abstract-linked awards

To apply for an abstract-linked award, you must complete the application coversheet using the upload functionality in the online abstract submission portal

Ann Woolcock New Investigator Award

Boehringer Ingelheim COPD Travel Award (AU)

Boehringer Ingelheim COPD Travel Award (NZ)

Janet Elder International Travel Award

Japanese Respiratory Society (JRS) Early Career Development

TSANZ Travel Grants to 2019 ASM

For more information visit http://www.tsanzsrs2019.com/abstracts/tsanz-awards-criteria/

Abstracts close 12 October 2018 6pm AEST

Research and Career Development Awards

TSANZ Peter Phelan Research Award – closes 31 Oct 18

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 31 Oct 18

TSANZ Indigenous Respiratory Nursing Award – closes 31 Oct 18

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease – closes 18 Nov 18

Maurice Blackburn ASM Travel Award – closes 18 Nov 18

Boehringer Ingelheim COPD Research Award – closes 3 Dec 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 31 Oct 18

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closes 31 Oct 18

Cystic Fibrosis Australia Awards

Cystic Fibrosis Innovation Grant – closes 28 Jan 2019

Lung Foundation Australia Awards

The Lung Foundation Australia David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis 2019 – closes 10 Oct 18

Lung Foundation Australia/ Cochrane Airways Australia Scholarship 2019 – closes 2 Nov 18

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Cystic Fibrosis Innovation Grant

Cystic Fibrosis Australia (CFA) is pleased to announce the 2019 Innovation Grant for post-doctoral researchers, currently working in cystic fibrosis (CF) research. This grant is awarded annually to one applicant for one year.

The Innovation Grant will allow a CF researcher to explore novel concepts at the initial feasibility stage.  Innovative applications relating to any aspect in the field of CF are encouraged, even those lacking pilot data.  The grant aims to allow the researcher to generate sufficient data within the one-year grant period to be in a position to apply for additional support from an appropriate funding body to continue the research.

The Innovation grant will be offered to post-doctoral researchers currently working in or proposing to work in CF research.  The researcher will have completed a research higher degree in CF or a related area within the last ten years.

The recipient of the Innovation Grant is required to provide progress reports on their research to CFA every six months.  In addition, and where appropriate, the recipient will be asked to make a presentation at a CFA conference (held every two years) in Australia.

The maximum amount awarded under the Innovation Grant will be $80,000.  The actual amount provided will be subject to approval of the applicant’s budget.

Applications can be made through the website of The Thoracic Society of Australia & New Zealand (TSANZ) and must be received by TSANZ by late January 2019.

Apply Here

TSANZ Webinar Series

Thursday 11th October 2018, 1pm AEDT | 3pm NZDT

Research Techniques to Study Respiratory Diseases – Prof Phil Hansbro

The webinar will be discussing a range of techniques that are valuable for studying disease, identifying new therapeutic targets and testing novel treatments. 

Professor Phil Hansbro Biography:

Professor Hansbro is a group leader and holds a personal chair in immunology and microbiology at the Hunter Medical Research Institute and University of Newcastle, Australia and is Associate Director of the Priority Research Centre for Asthma and Respiratory Diseases there. He is also an NHMRC Principal Research Fellow. He has established internationally recognised research programs in infections, COPD, asthma and recently lung cancer. His group has developed several novel mouse models of the important diseases (COPD, severe, steroid-insensitive asthma, early life infection & lung cancer). He has interrogated them (immune, histological, pathological, lung function & molecular analysis) to substantially further our understanding of pathogenesis and to develop novel therapies. He performs complimentary collaborative clinical and multi-disciplinary studies and collaborates widely. He publishes extensively in influential journals and he is regularly invited to present internationally including as plenary and to chair sessions. He has a substantial funding record of obtaining nationally competitive grants that support his group. He undertakes substantial mentoring and supervision activities of junior researchers, regularly sits on grant review panels and is on the editorial board of 4 journals. He is an active advocate for respiratory research in lobby groups and is regularly in the press promoting research and funding.

CLICK HERE to register! 

________________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars with Professor Allan Glanville and Sally Powell are now available for on-demand viewing. For more information, please CLICK HERE!

Thoracic Society Medals and FThorSoc

Each year the TSANZ invites members to nominate their peers to be considered for a number of prestigious awards, namely: Research Medal, Society Medal and 50th Anniversary Medal for Education & Training. Nominations for these awards are now invited from members of all backgrounds and professions. Recipients of these awards will be presented with their medals at the TSANZSRS 2019 Gala Dinner and Awards Evening.  

Members are also encouraged to consider applying to become a Fellow of TSANZ. Applications for Fellow status are reviewed by the Professional Standards Subcommittee and reviewed and endorsed by the Board. Fellow status is available to members from all professions who demonstrate an exceptional contribution to the field of respiratory health in Australia or New Zealand. If the Fellow status is approved, the member will be able to use the post nominal FThorSoc and will be able to continue to do so whilst a financial member of TSANZ. Recipients of the post nominal FThorSoc will be announced at the AGM 2019.

The Research Medal, Society Medal, 50th Anniversary Medal and Fellows of TSANZ are distinctive awards – a testament of the recipients’ exceptional contributions in the field of respiratory health in Australia or New Zealand.

Read below for more details & how to apply/nominate your peers. Closing date: Friday 2nd November 2018

TSANZ Fellowship 

DOWNLOAD APPLICATION FORM

For more information please visit: https://www.thoracic.org.au/about-us/fellow-of-thoracic-society-australia-new-zealand

Background:

The TSANZ Board makes an annual call for nominations for members to be awarded Fellow status. The call is made to members from all professions who demonstrate exceptional contribution to the field of respiratory health in Australia or New Zealand. If the Fellow status is approved, the member will be able to use the post nominal FThorSoc and will be able to continue to do so whilst a financial member of TSANZ.

The main aims of the Fellow status are:

  1. To recognise expertise and experience in respiratory medicine and/or research and/or respiratory health service provision.
  2. To acknowledge a major contribution and commitment to advancing respiratory health in Australia and/ or New Zealand.

Requirements for Awarding of FThorSoc:

TSANZ members may apply to become a Fellow of the Thoracic Society of Australia and New Zealand (FThorSoc) if they demonstrate exceptional contribution to 5 of the 7 criteria listed below. For the remaining 2 criteria, the applicant must demonstrate a proven track record.

The criteria are:

  1. A continuous financial member of TSANZ for five consecutive years in Australia and/or New Zealand as well as a minimum of ten years post-specialist qualification
  2. Contribution to advocacy and/or policy development
  3. Service within the community
  4. Distinguished leadership
  5. Contribution to research
  6. Contribution to teaching or training
  7. International recognition in his or her discipline

List of Fellows of The Thoracic Society Australia and New Zealand:

The following individuals have been nominated by their peers, recommended to the Board by the Professional Standards Sub-Committee and formally recognised by the Board for their exceptional contributions to respiratory health in Australia and New Zealand.

FTHORSOC 2013

FTHORSOC 2014

FTHORSOC 2015

FTHORSOC 2016

FTHORSOC 2017 

FTHORSOC 2018 

___________________________________________________________

Awards By Nomination

The Research Medal, Society Medal and 50th Anniversary Medal are awards for distinguished service. Nominations for each of these awards are invited as outlined below. 

 

The Research Medal 

About 

The Research Medal may be awarded each year in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in their field of research.

HOW TO NOMINATE

Candidates

The Research Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved Research Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate.  

The Society Medal 

About

The Society Medal was conceived as an acknowledgement of excellence in fields other than research, i.e. for the advancement of the practice of thoracic medicine in its widest sense by outstanding teaching or advocacy. The inaugural Society Medal was presented at the annual dinner in Canberra in 1992 to Dr Maurice Joseph, who ably embodied the qualities envisaged by this senior prestigious award.

HOW TO NOMINATE

Candidates

The Society Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved Society Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate.  

The 50th Anniversary Medal for Education and Training 

About

The 50th Anniversary Medal is an award introduced in 2011 to mark the Society’s 50th Anniversary. The 50th Anniversary Medal may be awarded each year in recognition of outstanding contributions to respiratory education and training in New Zealand or Australia. The award recognises an individual who has demonstrated sustained excellence in education and training. This might take the form of formal and informal teaching within a university, hospital or other health care setting; curriculum development at an undergraduate or postgraduate level; using research to enhance the efficacy of educational activities; career mentoring of junior members of the Society; integration of teaching into clinical practice; or advocacy on behalf of medical education as applied to respiratory medicine.

HOW TO NOMINATE

Candidates

The 50th Anniversary Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved 50th Anniversary Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate. 

Clinical Trials Workshop

The Centre of Excellence is pleased to be hosting a Clinical Trials Workshop on 24 October 2018 from 1 – 4PM at the Hunter Medical Research Institute, Caves Theatre. We believe this session will be of broad interest and would appreciate your support in distributing this invitation as broadly as possible.

We are pleased to confirm 4 experts in the field presenting on:

1:00 – 1:40: Clinical Trials Funding (Prof. Bruce Neal, The George Institute)

1:40 – 2:50: Integrating Public Involvement in Research and Clinical Trials (Prof. William Tarnow-Mordi, NHMRC CTC & Melinda Cruz, Miracle Babies Foundation)

3:20 – 4:00: Designing Implementation Trials (Prof. John Wiggers, University of Newcastle)

An event flyer can be downloaded at: https://www.severeasthma.org.au/wp-content/uploads/2018/09/24Oct2018-Clinical-Trials-Workshop.pdf

Lunch will be served before the event and refreshments during an intermission. Please RSVP your interest for catering purposes to severeasthma@newcastle.edu.au

Respirology – Editor’s Choice

Respirology Issue 23.10 (October 2018)

Annual Southeast Asia haze increases respiratory admissions: A 2-year large single institution experience.

Chew R. Ming, Andrea Ban Yu‐Lin, Mohammad F. Abdul Hamid, Mohd T. Latif, Nurashikin Mohammad, Tidi Hassan

DOI: 10.1111/resp.13325

 

Satellite image of the 2015 SE-Asia haze

 

GeneXpert MTB/RIF for rapid diagnosis and rifampin resistance detection of endobronchial tuberculosis

Qin Zhang, Qing Zhang, Bing‐qi Sun, Chang Liu, An‐na Su, Xiao‐han Wang, Na Liu, Juan Zhang, Jian Kang, Gang Hou

DOI: 10.1111/resp.13316

 

The research team from Shenyang, China, with the GeneXpert MTB/RIF system. From left to right: Xiao-han Wang, Chang Liu, Qin Zhang, Bing-qi Sun (front row); Qing Zhang, Gang Hou, An-na Su, Na Liu (Back row).

Research Project and Survey Requests

Implementation of Severe Asthma Management

About the Survey:

On behalf of the NHMRC Centre of Excellence in Severe Asthma (www.severeasthma.org.au), we request your assistance in completing a short survey regarding the implementation of management strategies for severe asthma. We are seeking feedback from multidisciplinary healthcare professionals in Australia.

The survey is available at the following link: https://www.surveymonkey.com/r/SevereAsthmaCRE

The results from this survey will inform expert forum discussions, ongoing research and development of resources to support translation and implementation of new findings into clinical practice. Our goal is to use this information to develop improved standards of care through the NHMRC Centre of Excellence in Severe Asthma.

This survey consists of 15 questions and we anticipate it will take less than 10 minutes to complete.

If respondents can submit their responses by Friday 02 November 2018 it will be greatly appreciated.

Thank you and kind regards,

Profs. Peter Gibson, Vanessa McDonald and John Upham, on behalf of the Centre of Excellence in Severe Asthma

This survey has been approved by the HNELHD HREC under authorisation number AU201809-09. All responses are completely anonymous and will be kept strictly confidential. If you experience any issues or have any questions, please contact: severeasthma@newcastle.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 3.03 JUNE 2018

Research Roundup:

June 2018

.
 

Welcome Message

We are deep in conference season with both the TSANZSRS18 and the ATS Congress now finished for another year. At TSANZSRS18, respiratory research received a much needed boost of over $2 million funding from TSANZ, LFA, CFA, NAC, and our partners. These awards were announced at the Respiratory Research Excellence Awards session and we hope you enjoyed this new -look celebration. You can recap the TSANZ research winners on our website. ATS Congress was another huge event and we invite you to look at the limbic stories below for highlights. The next international meeting in the respiratory circuit is the ERS Congress in Paris Sept 15-19. There are ERS travel awards available still so please look into these if you are planning on attending. 

We would also like to highlight the funding opportunities available for those researching alpha-one antitrypsin deficiency in lung disease. There are large grants on offer from the Alpha One Association and these do not require any specific membership and international collaborations for eligibility.

Furthermore, the Thoracic Society Research Medal and other awards by nominations are now open. Please consider nominating a member in recognition of their outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand.

Finally, I encourage you all to complete the survey at the end of this newsletter in regards to The Global Lung Function Initiative (GLI). The GLI has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations. They are now seeking feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation.

Enjoy the June edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

TSANZ NZ Branch ASM Travel Grant – closing 14 Jul 18

Vertex Cystic Fibrosis Research Awards – NACFC closing 08 Aug 18

Lung Foundation Australia / A Menarini Pty Ltd 2018 Travel Awards – ERS closing 29 Jun 18, APSR closing 09 Jul 18

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Support TSANZ

This year, TSANZ is asking members to provide a tax deductible donation to support our work in respiratory research and/or clinical care. You can choose to donate to one, or both, of the programs detailed below:

1. TSANZ 50th Anniversary Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor. In 2018, this program supported the development of two clinical programs:

  • Take the Bronchiectasis Toolbox on the road: A program aiming to build upon the tremendous work of the Bronchiectasis Toolbox by increasing its effectiveness in in Australia’s regional and remote areas. TBTR is designed to bridge the gap between electronic platform and clinician by supplementing the Toolbox’s online content with face-to-face educational workshops, as well as further online resources and telephone and email support.
  • A clinician’s guide to early diagnosis of PCD – when common symptoms mean so much more!: An online educational resource for medical staff to aid in the early and accurate diagnosis of Primary Ciliary Dyskinesia (PCD). This resource aims to increase medical awareness of suggestive symptoms as well as referral directions for diagnostic testing. This guide will not only better enable clinicians to identify PCD in its crucial early stages, but provide them with the knowledge of specific PCD therapy aims that they need to ensure their patients receive the best treatment possible.

 – CLICK HERE to make a donation.

2. Joint TSANZ/LFA Research Program

In 2018 were able to recognise three respiratory health researchers for their work in combating serious lung disease. The 2018 Lungs for Life Research Award winners were:

Professor Phil Hansbro: Cell free microRNA: potential biomarkers for the early detection of lung cancer

Dr Malcolm Starkey: Understanding how group 2 innate lymphoid cells in early-life regulate postnatal lung development and susceptibility to chronic lung diseases

Dr Megan Jensen: Maternal and Early Life Vitamin D exposure and asthma risk in high risk infants

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease. Please CLICK HERE to make a donation.

3. Leave TSANZ a gift in your will – If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy. If interested, please notify us by ticking the box on the Support TSANZ form attached. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

4. TSANZ New Zealand Branch IncorporatedCLICK HERE to make a donation.

New Zealand members are able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.

TSANZ Medals  

We apologise for the mistake we made in our latest article on the Society Medal in the May e-news. In response, we would like to congratulate the recipients of three prestigious TSANZ Medals: the Society Medal, the Research Medal, and the 50th Anniversary Medal. These awards are presented to TSANZ members as an acknowledgement of their outstanding contributions to respiratory health in research, education, and the health sector.

Nominations for the year have now opened! If you wish to nominate an extraordinary TSANZ member for their work in respiratory health, please visit https://www.thoracic.org.au/researchawards/tsanz-awards-by-nomination for more information.

Previous recipients of these prestigious TSANZ Medals are listed below:

The Research Medal

1992 Professor Ludwig Engel (posthumously) 
1994 Professor Colin Sullivan
1996
Professor Terry Nicholas
Professor Peter Phelan
1998 Professor Judith Black
1999 A/Professor Philip Thompson
2000 Professor Richard Beasley
2003 A/Professor Peter Gibson
2005 Professor Peter Sly
2006 A/Professor Gary Anderson
2007 Professor Haydn Walters
2008 Professor Bruce Robinson
2009 Professor Peter Bye
2010
Professor Guy Marks
2011
Professor Bill Musk
Professor Michael Abramson
2012 A/Professor Paul Forrest
2013 Professor Anne Chang
2014 Professor Scott Bell
2015 Professor Richard Beasley
2016 Professor Ron Grunstein
2018 Professor Peter Le Souef

 

 

The Society Medal

1992 Dr Maurice Joseph
1993 Dr Roy Mills
1994 Professor Tom O’Donnell
1995 Dr Michael Pain
1996 Dr Alastair Campbell (posthumously)
1997 Dr Michael Burns
1998 Professor Ann Woolcock
1999 Dr Kevin Finucane
2002 Dr Peter Rothwell
2004 Dr Abraham Rubinfeld
2006 A/Professor Charles Mitchell
2008 Dr Bob Edwards
2011 Judge John O’Meally
2012 Professor Norbert Berend
2013 Professor Philip Thompson
2014 Professor Peter van Asperen
2015 Professor Martin Phillips
2016 Professor Iven Young
2017 Professor Peter Holmes
2018 Professor Paul Reynolds

 

50th Anniversary Medal

2011 Dr Paul Zimmerman 
2012
A/Professor Tara Mackenzie 
2013 Professor Fiona Lake
2014 A/Professor Chien-Li Holmes-Liew 
2015 Professor Hubertus Jersmann
Dr Nicholas Saltos
2016 Professor Peter Frith
2017 Professor Jennifer Alison
Professor Richard Ruffin

 

Respirology Issue – Editor’s Choice

Vitamin D and respiratory health in the Busselton Healthy Ageing Study

SIOBHAIN MULRENNAN, MATTHEW KNUIMAN, JOHN P. WALSH, JENNIE HUI, MICHAEL HUNTER, MARK DIVITINI, KUN ZHU, BRIAN R. COOKE, ARTHUR W. (BILL) MUSK and ALAN JAMES

DOI: 10.1111/resp.13239

 

A Busselton Health Study participant undergoing lung function testing

 

Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema

JOSEPH JACOB, BRIAN J. BARTHOLMAI, SRINIVASAN RAJAGOPALAN, RONALD KARWOSKI, ARJUN NAIR, SIMON L.F. WALSH, JOSEPH BARNETT, GARY CROSS, EOIN P. JUDGE, MARIA KOKOSI, ELISABETTA RENZONI, TOBY M. MAHER and ATHOL U. WELLS

DOI: 10.1111/resp.13231

 

The Royal Brompton Hospital in South Kensington, London, UK (left), and the Mayo Clinic in Rochester,  MN, USA  (right).

 

Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy

JUNYA OKUMURA, YUICHIRO SHINDO, KUNIHIKO TAKAHASHI, MASAHIRO SANO, YASUTERU SUGINO, TETSUYA YAGI, HIROYUKI TANIGUCHI, HIDEO SAKA, SHIGEYUKI MATSUI, YOSHINORI HASEGAWA on behalf of the Central Japan Lung Study Group

DOI: 10.1111/resp.13232

 

The Nagoya University Respiratory Tract Infection Team studied approximately 1500 patients with pneumonia from 10 different hospitals on behalf of the Central Japan Lung Study Group.

 

Diagnostic utility of surgical lung biopsies in elderly patients with indeterminate interstitial lung disease 

LASZLO T. VASZAR, BRANDON T. LARSEN, KAREN L. SWANSON, JAY H. RYU AND HENRY D. TAZELAAR

DOI: 10.1111/resp.13223

 

The research team from the Mayo Clinics in Scottsdale, AR, and Rochester, MN, USA, from left to right: Karen L Swanson, Henry D Tazelaar, Laszlo T Vaszar, Brandon T Larsen and Jay H Ryu (inset top right).

 

Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial

STEVEN MCKINSTRY, JANINE PILCHER, GEORGE BARDSLEY, JAMES BERRY, SUSANNE VAN DE HEI, IRENE BRAITHWAITE, JAMES FINGLETON, MARK WEATHERALL and RICHARD BEASLEY

DOI: 10.1111/resp.13185

 

Nasal High Flow therapy in action

 

Pharmacokinetics and safety of paclitaxel delivery into porcine airway walls by a new endobronchial drug delivery catheter

HISASHI TSUKADA, PLAMENA ENTCHEVA-DIMITROV, ARMIN ERNST, SAMAAN RAFEQ, JOHN H. KEATING, KIRK P. SEWARD and LONNY YARMUS

DOI: 10.1111/resp.13214

 

The Blowfish® Transbronchial Micro-Infusion Catheter

 

Research Project and Survey Requests

The Global Lung Function Initiative (GLI) Survey

The Global Lung Function Initiative (GLI) has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations.   

 As part of our broader work we are interested in receiving feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation. We would greatly appreciate you taking the time to complete the survey to help us understand the experiences of your own research group and/or clinical department.  

This short survey should take ~ 5 minutes to complete and will assist in further informing GLI activities and how we approach future implementation. Individuals and their institutions will not be identified. Outcomes of the survey will be made publicly available on the GLI website. 

We are currently working to develop reference equations for lung volumes and if you or your colleagues have lung volume data in healthy individuals please do visit www.lungfunction.org for more information on this latest GLI initiative.  

Survey sent on behalf of the Global Lung Function Initiative Network: 

https://www.surveymonkey.com/r/DB9LYDJ?PleaseSpecify=[PleaseSpecify_value]

Explaining chronic breathlessness

Chronic breathlessness has been defined as ‘breathlessness that persists despite optimal treatment of underlying pathology and results in disability’ (Johnson et al. Eur Respir J 2017;49 (5)). This symptom is a common daily experience for people with a range of malignant and non-malignant respiratory, cardiovascular and neuromuscular conditions.

We know very little about how health professionals explain chronic breathlessness to people living with this symptom. This survey seek to collect information on the  explanations health professionals, from a variety of professional disciplines, use when explaining chronic breathlessness  to people living with this symptom (and their views on whether there is specific information which should  and should not be included in explanations). 

This electronic survey contains 13 questions and should take not more than 10 -12 minutes to complete. All responses will be confidential and anonymised by allocating an ID code to each participant. Details concerning the process including data management and privacy consideration are included in the Participant Information sheet included within the opening screens of the survey.

Ethical approval has been received from the Human Research Ethics Committee of the University of South Australia (ID: 200896)

For further information or to participate, please click here: 

Explain chronic breathlessness’   or copy and paste the following into your browser:

https://www.surveymonkey.com/r/Explain-Chronic-Breathlessness

For further information please contact Dr Marie Williams (E: marie.williams@unisa.edu.au or Ph: +61-8-8302 1153, University of South Australia) on behalf of the research team (Dr Kylie Johnston and Prof Dina Brooks)

 
 
 
 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 2.5 JUNE 2017

Research Roundup:

June  2017

.
 

Welcome Message

At the end of last month the NHMRC announced the grant program restructure. These changes will consolidate support for investigators and boost funding for ideas. Grants will also be larger with the aim to achieve greater gains and reduce the burden of writing grants. I have recently returned from the American Thoracic Society Conference and saw these changes in funding models are being reflected internationally, with major changes in NIH funding models similar to what we are seeing with the NHMRC.

I would like to draw your attention to the Public consultation on “A Framework for NHMRC Assessment and Funding of Clinical Trials and Cohort Studieswhich is now open on the NHMRC Public Consultations Portal. The consultation paper is available here. TSANZ will submit a response to this consultation on behalf of the society and you are encouraged to send in your opinion to the office to ensure our response is representative of our membership. Please let us know your opinion on this by the 29th of June by responding to TSANZoffice@thoracic.org.au

For now, I will leave you with the many awards we are hosting, and the long list of direct-to-researcher funds which have been identified below, through  the Lungs for Life project. Respirology has also supplied us with their Editor’s Choice articles, again featuring our members.

Enjoy the June edition of your research roundup.

Prof Phil Hansbro

Chair, Research Sub-Committee

The following articles will take you to thelimbic.com

Better bedside management of pleural effusions. Brisbane doctors have significantly improved the outcomes of patients with pleural effusions by giving registrars and trainees practical hands on training on the use of pleural ultrasound. Read More.

Integrating palliative and respiratory care is possible. Patients with COPD and their doctors are reluctant to consider palliative care however a new model of care might help with that. Read More.

Oxygen saturation should be the 5th vital sign. A pulse oximeter should be as ubiquitous as a stethoscope, according to the British Thoracic Society’s new guidelines. Read More.

Non-invasive ventilation cuts COPD readmissions. Hard to treat patients with frequent COPD exacerbations can be kept out of hospital for longer when NIV is added to home oxygen. Read More.

No need to wait for Europe on severe eosinophilic asthma. The European respiratory community is working towards consensus on the diagnosis and management of severe eosinophilic asthma but there’s no need to wait for them, according to an Australian expert. Read More.

Fake stone a lung hazard. Scores of people who work with a product hailed as a cheap alternative to marble and granite could be at risk of developing a debilitating lung disease, Australian respiratory physicians warn. Read More.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM Travel Grant – Supported by GSK  Deadline extended – 28 July 2017

These travel awards are made available to encourage eligible TSANZ members to attend and enrich the NZ Annual Scientific Meeting through presentation of their work and active participation in the meeting.

There will be seven awards of $NZ500 to support the career development of TSANZ nurses and allied health professionals.

Vertex Paediatric Cystic Fibrosis Clinical Fellowship

The TSANZ Vertex Cystic Fibrosis Paediatric Clinical Fellowship supports an articulated training program for advanced trainees who are currently, or who wish to sub-specialize in Paediatric Respiratory Medicine, specifically to conduct the research, diagnosis and management of cystic fibrosis in Australia and New Zealand.

This is a unique opportunity to secure a fellowship that supports clinic based training in a Paediatric specialty area.

The fellowship shall be to the value of AUD$50,000 per annum for two years.

Vertex Adult Cystic Fibrosis Fellowship

The TSANZ Vertex Adult Cystic Fibrosis Fellowship will support a health practitioner or research scientist working in respiratory medicine who wishes to undertake research into adult cystic fibrosis, accompanied with professional development in adult cystic fibrosis in Australia or New Zealand.

This is a unique opportunity to secure a fellowship that supports either research and/or clinic based training / professional development in the adult cystic fibrosis specialty area.

The fellowship shall be to the value of AUD$50,000 per annum for two years.

Vertex Cystic Fibrosis Research Awards

To foster ongoing original cystic fibrosis research and its communication internationally.

The winners of the awards (2) will receive an award up to the value of AUD$7500 each to support their economy class travel, registration and accommodation to present their research at the European Cystic Fibrosis Society Annual Meeting or the North American Cystic Fibrosis Conference.

Lungs for Life Awards

Lungs for Life Research Awards – Closing soon – 30 June 2017

This Research Award aims to provide seed funding for critical and impactful areas of respiratory research. Preference will be given to research proposals in the priorities areas of early lung development, infection, and lung cancer. Three research proposals will be funded.

The Research Award value will total $40,000. Funds will be offered as $20,000 from Lungs for Life and must be matched with equal or greater funding from the applicant’s institution.

Lung Foundation Australia Awards

Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to health professionals/researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

Cystic Fibrosis Australia Awards

Abbie Fennessy Memorial Fellowship (Sponsored by Technipro-Pulmomed Pty Ltd). More Information [PDF] | Application form [word doc]

The aim of the Fellowship is to improve the knowledge and skills of Allied Health & Nursing professionals working in Cystic Fibrosis care to benefit those who have Cystic Fibrosis. The award provides up to $5000 to support education, training, academic purposes, and/or medical research, activities that improve the quality of medicine and the improvement of Cystic Fibrosis patient outcomes.  The Fellowship is open to Allied Health & Nursing professionals involved in the treatment or care of people with Cystic Fibrosis in Australia.

Watch this space for more award announcements…

icare dust diseases care Scholarships and Fellowships

 

Lungs for Life Grant Bulletin

The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late June and September, 2017:

Wellcome Trust Pathfinder Awards – closes 20/06/17
The diagnosis, prevention and treatment of orphan and neglected diseases that present an unmet medical need. Seeking to fund pilot studies to develop assets and de-risk future development.

Australian Cancer Research Foundation (ACRF) Cancer Research Grants – closes 23/06/17
Seeks to support all aspects of cancer research and control including but not limited to: cell or molecular biology, epidemiology, early detection, prevention and drug development. Focused on seed funding; primarily providing capital grants for major equipment, and the establishment of capital works and facilities. Collaborative projects between institutions are encouraged.

John T Reid Charitable Trusts – opens 06/07/17 and “closes once a volume of applications have been received”.
The John T Reid Charitable Trusts is a national funding organisation with a wide ranging commitment to philanthropy around Australia. Funding focus is on community and social welfare, health support, aged and palliative care, education and youth support, arts and cultural heritage and the environment.

The Sir Robert Menzies Memorial Research Scholarship in the Allied Health Sciences – closes 30/06/17
The purpose of the scholarship is to try to improve the health of Australians by supporting an outstanding applicant from one of the non‐medical allied health disciplines, or from an applicant who is working directly in applied clinical research.

The John Burge Trust – closes 30/06/17
The John Burge Trust was established by the late John Burge to assist people with tuberculosis and support work towards the prevention and cure of the disease. This can include: educational programs for health workers; aid and help for tuberculosis sufferers and who by reason of the disease are disabled; medication; research.

Shepherd Foundation Research Grants – closes 01/07/17 and 15/09/17
For research projects in all aspects of preventative medicine and/or occupational medicine. Applicants may apply for funding of one, two or three years.

Lung Cancer Research Foundation Grants 2017 – closes 01/07/17
Lung cancer projects focused on one or more of the following: basic science; translational research; clinical research; supportive care; quality of care/outcomes.

GlaxoSmithKline Australia Award for Research Excellence – closes 10/07/17
Recognition for an outstanding researcher with a demonstrated track record of significant work in human medical health, and for whom the award will facilitate career development and further achievements.

2017 Research Australia Health and Medical Research Awards – closes 17/07/17
Research Australia’s annual awards recognise significant contributions to health and medical research.

The Alan Westcare Project Grant – closes 31/07/17
The Alan King Westcare Project Grant is a 12 month $50,000 grant to available to laboratory, clinical and epidemiological research into the cause, diagnosis, prevention and treatment of respiratory infections such as tuberculosis.

CSL Centenary Fellowships 2017 – closes 31/07/17
To foster excellence in Australian medical research by supporting mid-career Australian scientists to pursue world class medical research. The fellowship provides for a full-time salary (generally equivalent to a Senior Research Fellow C1 level) plus research costs and/or a post-doctoral research assistant. The breakdown is determined by the Fellow, in conjunction with the employing institution at the commencement of the Fellowship. The fellowships are primarily awarded for discovery and translational research with a focus on rare and serious diseases, immunology, and inflammation. However, those who meet the eligibility are strongly encouraged to submit an application for their medical research project.

Centenary Institute Medical Innovation Award 2017 – closes 31/07/17
The Prize focuses on creativity – the essential ingredient in all human endeavour, whether in science, art or marketing. It will be presented to the biomedical research scientist based in Australia who demonstrates the greatest creativity in their scientific approach in a given year. Valued at $36,000.

Westpac Bicentennial Foundation Research Fellowship – closes 31/08/17
The Westpac Research Fellowship supports outstanding early career researchers whose ground-breaking work has the potential to make a difference in one of the Foundation’s focus areas: Technology and innovation, Strengthening Australia-Asia ties, and Enabling positive social change.

Westpac Bicentennial Foundation Social Change Fellowship – closes mid-August/2017
The Westpac Social Change Fellowship is an opportunity to invest in your capability, knowledge and networks with a view to helping you bring to life your innovative initiative for positive social change in Australia.

Rebecca L Cooper Medical Research Foundation – Medical Research Grants – closes 01/09/17
Advancing, promoting and encouraging medical research into Brain Sciences (psychiatry and neurology), Endocrinology and Diabetes, Geriatrics, Lung Disease (other than cancer), Rheumatology, Vision Sciences. Funding is primarily granted for the purchase of equipment, but may be used for other tangibles (e.g. therapeutic or imaging markers, software etc.). Funding requests for salaries/wages are not strongly supported, but will be considered by the directors.

The Prince Charles Hospital Foundation Emerging Researcher Grant – closes 01/09/17
The Emerging Researcher Grant is aimed at providing New Investigators who have previously received and successfully completed a New Investigator grant from TPCHF the opportunity to further develop their skills, experience and build the research capacity of TPCH The priority areas are: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

Harkness Fellowships in Health Care Policy and Practice 2018-2019 – closes 05/09/17
For mid-career professionals (academic researchers, government policymakers, clinicians, managers, and journalists) from Australia, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United Kingdom, to spend up to 12 months in the US conducting a policy-oriented research study, working with leading US health policy experts, and gaining an in-depth knowledge of the US and other health care systems.

Future Research Leader Fellowships – EOI closes 15/09/17
5 year full time Fellowships to provide salary and project support to encourage high calibre interstate and international emerging researchers to develop a program of work that support the activities that are being undertaken by the Translational Cancer Research Centres (TCRCs) in NSW. Applications must be in the area of implementation research and, more specifically, should address how research findings from the TCRCs can be taken up into routine cancer care.

Conquer Cancer Career Development Award – closes 21/09/17
Provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Submissions in all oncology sub specialties are welcome.

Financial Markets Foundation for Children – closes 30/09/17
Research programs designed to improve the health, welfare and wellbeing of Australian children. Preference will be given to projects focussed on children aged 14 years and under, although the Foundation will consider projects relating to children up to 18 years of age.

Cancer Research Institute CRI Irvington Postdoctoral Fellowship Program – closes 01/10/17
Supports qualified young scientists at leading universities and research centres around the world who wish to receive training in cancer immunology. An eligible project must be immunology with direct relevance to solving the cancer problem.

Rolling Grants

Boehringer Ingelheim Fonds Travel Grants
Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

Baxalta Bioscience Grants – Medical Education & Fellowship Grants
Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

Coopers Brewery Foundation – current round closes 01/08/2017
Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

The Balnaves Foundation
The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

 

PhD Scholarships

PhD Scholarship opportunity available at the University of Newcastle: Maternal and early life nutritional status and respiratory health of the offspring.

Please see flyer for more information [PDF]

Applications close 31st July, 2017.

Respirology

Respirology Issue 22.5

Airflow limitation severity and post-operative pulmonary complications following extra-pulmonary surgery in COPD patients.

Beomsu Shin, Hyun Lee, Danbee Kang, Byeong-Ho Jeong, Hyung Koo Kang, Hae Ri Chon, Won-Jung Koh, Man Pyo Chung, Eliseo Guallar, Juhee Cho and Hye Yun Park

DOI: 10.1111/resp.12988

 

From left to right: Juhee Cho, Hye Yun Park, Hyun Lee, Danbee Kang and Beomsu Shin from South Korea

 

Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry

IAN N. Glaspole SALLY A. Chapman, WENDY A. Cooper, SAMANTHA J. Ellis, NICOLE S. Goh, PETER M. Hopkins, SACHA Macansh, ANNABELLE Mahar, YUBEN P. Moodley, ELDHO Paul, PAUL N. Reynolds, E.HAYDN. Walters, CHRISTOPHER J. Zappala  and TAMERA J. Corte

DOI: 10.1111/resp.12989

 

National spread of participants of the Australian Idiopathic Pulmonary Fibrosis Registry recruited from all states and territories in Australia.

Research Project and Survey Requests

‘Usual’ antenatal asthma management

Dear Colleague,

Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma management consists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

Ethics approval has been granted for this study. All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser: https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

 

Recruiting for new study investigating the effects of ambulatory oxygen therapy via portable concentrator in interstitial lung disease

Researchers at Austin Health are currently recruiting patients with chronic interstitial lung disease and exertional desaturation (< 90% on room air during the 6-minute walk test) for a randomized controlled trial investigating the effects of ambulatory oxygen therapy via portable concentrators. Inclusion and exclusion criteria are in the link below. 

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371748&isReview=true  

If you wish to discuss possible patients for screening and enrolment or receive further information, please contact Yet Hong Khor on 03 9496 5390 or YetHong.Khor@austin.org.au.

This study has been approved by the Austin Health Human Research Ethics Committee.

 

Are you interested in helping us further our understanding of healthcare professionals’ perceptions of asthma using an innovative method – drawings?

If so, and you are a healthcare professional, you are invited to take part in a research study exploring the use of drawings to further understanding of healthcare professionals’ perceptions of the experience of asthma.

An emerging approach for investigating people’s perspectives of illness is the use of drawings. Despite the high prevalence of asthma, there is yet to be research using drawing to explore healthcare professionals’ perceptions of the experience of asthma in the Australian population. Drawings may be useful for expression and could increase our understanding of the perspective of healthcare professionals involved in asthma management. The total time commitment is expected to be approximately one hour. You will be reimbursed for your time.

If you would like more details or would like to take part, please contact the researchers (details below). Thank you!

A/Prof Lorraine Smith, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9036 7079

Melissa Cheung, PhD Candidate, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9351 3710

 

Paediatric PFT needs assessment

We are undertaking a project to assess and address the needs of the global paediatric pulmonology/respirology community for practice guidelines for paediatric pulmonary function testing in both the clinical and research settings.

The first step in this project is to define and understand those needs via a short (less than 5 minute) survey. We ask that you complete this brief survey to help us understand how to best meet the needs of our community. Please click on the link below to complete the survey online.

Survey

Thank you for your time.

Nitin Kapur, Paediatric SIG Convenor

on behalf of 

Members of the American Thoracic Society/European Respiratory Society Infant & Preschool Pulmonary Function Testing Working Group and the European Respiratory Society Pediatric Respiratory and Sleep Physiology Working Group:

Graham Hall, BSc PhD
Jessica Pittman, MD MPH
Padmaja Subbarao, MD MSc FRCP
Claudia Calogero, MD
Stephanie Davis, MD
Margaret Rosenfeld, MD MPH

 

Barriers and Facilitators to Optimal use of Acute Oxygen Therapy in Adults

Dear colleagues,

Our research  team is conducting a study to investigate the  barriers, facilitators and attitudes of health care professionals towards the prescription and delivery of oxygen therapy in the acute care setting. We hope that the results from this study will provide information that will be used to inform and facilitate the translation of evidence based guidelines into clinical practice.

As a clinician who delivers care to patients who use oxygen therapy, we understand that your views and opinions are important. You are invited to participate in this voluntary online survey. It is expected that this should take no longer than 15 minutes. There are no correct or incorrect responses, this survey is designed to explore your opinions regarding acute oxygen therapy.

This study has been granted ethics approval by Hunter New England Human Research Ethics Committee  (Approval number: 16/04/20/5.03) and the University of Newcastle Human Research Ethics Committee (Reference Number: H-2016-0222). For further information you can view the participant information HERE.

There are no anticipated risks to you for taking part in this survey. Information that you provide will be anonymous and remain confidential. Only those directly involved in this research have access to any answers that you provide. Participation in the survey implies consent and can be completed by clicking  the  OXYGEN SURVEY LINK HERE.

Please feel free to contact us directly if you have any questions regarding this research.

We thank you in advance for participating and ask you to consider forwarding this survey to other colleagues, who also deliver care to patients with oxygen therapy.

Kind Regards

Professor Vanessa McDonald
Professor Peter Wark
Joyce Cousins (PhD Scholar)
Contact: joyce.cousins@uon.edu.au

 
 

 

 

 

 
 
 
 
 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 2.4 MAY 2017

Research Roundup:

May  2017

.
 

Welcome Message

This edition of the Research Roundup is full of open awards which are quite varied in who and what they support. However, I would like to highlight the Lungs for Life Research Awards, which are seed grants purely to support respiratory research. We want these grants to support the generation of data which can be used for larger projects in the future. Research proposals for the Lungs for Life Research Awards may come from any area of respiratory medicine, however preference will be given to research into early lung development, lung cancer, and respiratory infectious disease, as they are the current priorities of this strategic project. These awards are an exciting opportunity and not to be missed.

For those of you heading off to the Congress of the American Thoracic Society, please make sure you drop into the TSANZ stand. Our CEO, Tanya will be on site and will welcome any visitors! I will also be there and hope to see you there enjoying the latest in respiratory research.

Enjoy the May edition of your research roundup.

Prof Phil Hansbro

Chair, Research Sub-Committee

The following articles will take you to thelimbic.com

Final thunderstorm asthma report needs to be broader. The final report on the emergency response to the unprecedented thunderstorm asthma event that affected thousands of people in Victoria last year demonstrates commitment to preventing similar events but needs to be broader, an expert says. Read More.

Integrity of large international trials in question. Large international randomised controlled trials, the cornerstone of modern medicine, are in big trouble. Read More.

Euthanasia debate killing the bigger picture. The persistent media and political focus on euthanasia has skewed the debate about end of life issues and diverted attention away from adequately resourcing palliative care services that would benefit many more people, an expert says. Read More.

Steroids risky in the short-term. A BMJ study that found an up to five-fold increased risk in fractures, blood clots and sepsis with short-term use of oral steroids is a wakeup call for clinicians to consider whether their use is evidence-based for the problem they’re treating. Read More.

Death by air pollution. Long-term exposure to fine air particles caused 4.2 million deaths and over 103 million lost years of healthy life in 2015, a global report of pollution levels over a quarter of a century shows. Read More.

Australian study most influential respiratory paper. The study has been highlighted by the American College of Physicians as one of the most influential studies in respiratory medicine to be published last year. Read More.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM Travel Grant – Supported by GSK

These travel awards are made available to encourage eligible TSANZ members to attend and enrich the NZ Annual Scientific Meeting through presentation of their work and active participation in the meeting.

There will be seven awards of $NZ500 to support the career development of TSANZ nurses and allied health professionals.

Vertex Paediatric Cystic Fibrosis Clinical Fellowship

The TSANZ Vertex Cystic Fibrosis Paediatric Clinical Fellowship supports an articulated training program for advanced trainees who are currently, or who wish to sub-specialize in Paediatric Respiratory Medicine, specifically to conduct the research, diagnosis and management of cystic fibrosis in Australia and New Zealand.

This is a unique opportunity to secure a fellowship that supports clinic based training in a Paediatric specialty area.

The fellowship shall be to the value of AUD$50,000 per annum for two years.

Vertex Adult Cystic Fibrosis Fellowship

The TSANZ Vertex Adult Cystic Fibrosis Fellowship will support a health practitioner or research scientist working in respiratory medicine who wishes to undertake research into adult cystic fibrosis, accompanied with professional development in adult cystic fibrosis in Australia or New Zealand.

This is a unique opportunity to secure a fellowship that supports either research and/or clinic based training / professional development in the adult cystic fibrosis specialty area.

The fellowship shall be to the value of AUD$50,000 per annum for two years.

Vertex Cystic Fibrosis Research Awards

To foster ongoing original cystic fibrosis research and its communication internationally.

The winners of the awards (2) will receive an award up to the value of AUD$7500 each to support their economy class travel, registration and accommodation to present their research at the European Cystic Fibrosis Society Annual Meeting or the North American Cystic Fibrosis Conference.

Lungs for Life Awards

Lungs for Life Research Awards

This Research Award aims to provide seed funding for critical and impactful areas of respiratory research. Preference will be given to research proposals in the priorities areas of early lung development, infection, and lung cancer. Three research proposals will be funded.

The Research Award value will total $40,000. Funds will be offered as $20,000 from Lungs for Life and must be matched with equal or greater funding from the applicant’s institution.

Lung Foundation Australia Awards

Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to health professionals/researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

Cystic Fibrosis Australia Awards

Abbie Fennessy Memorial Fellowship (Sponsored by Technipro-Pulmomed Pty Ltd). More Information [PDF] | Application form [word doc]

The aim of the Fellowship is to improve the knowledge and skills of Allied Health & Nursing professionals working in Cystic Fibrosis care to benefit those who have Cystic Fibrosis. The award provides up to $5000 to support education, training, academic purposes, and/or medical research, activities that improve the quality of medicine and the improvement of Cystic Fibrosis patient outcomes.  The Fellowship is open to Allied Health & Nursing professionals involved in the treatment or care of people with Cystic Fibrosis in Australia.

Watch this space for more award announcements…

icare dust diseases care Scholarships and Fellowships

 

Lungs for Life Grant Bulletin

The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late May and mid-2017:

The Prince Charles Hospital Foundation Experienced Researcher Project Grants – closes 20/05/17
To support strategic, world-class, sophisticated research on the Foundation’s campus or in significant partnership with this campus in the priority areas of: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

The NVIDIA Foundation Compute the Cure Cancer Research Grants – closes 28/05/17

To advance the fight against cancer. Will fund projects that use computational omics to dramatically impact the battle against cancer and reduce the time it takes for research outcomes to be used effectively in a clinical environment.

The Peer Prize for Women in Science 2017 – closes 31/05/17
This prize is for women researchers across Australia with a mission to accelerate open knowledge exchange and cross-disciplinary innovation.  The are two main areas of research focus: Life Sciences; and Earth, Environmental and Space Sciences. The prize for each category is $20,000.

Australian Institute of Policy and Science – CSL Florey Medal – closes 05/06/17
Award for an Australian biomedical researcher with significant achievements in biomedical science and/or human health advancement for research conducted primarily in Australia. Winners are expected to attend a presentation ceremony in Canberra in November.

Wellcome Trust Pathfinder Awards – closes 20/06/17
The diagnosis, prevention and treatment of orphan and neglected diseases that present an unmet medical need. Seeking to fund pilot studies to develop assets and de-risk future development.

Australian Cancer Research Foundation (ACRF) Cancer Research Grants – closes 23/06/17
Seeks to support all aspects of cancer research and control including but not limited to: cell or molecular biology, epidemiology, early detection, prevention and drug development. Focused on seed funding; primarily providing capital grants for major equipment, and the establishment of capital works and facilities. Collaborative projects between institutions are encouraged.

John T Reid Charitable Trusts – closes 28/06/17
The John T Reid Charitable Trusts is a national funding organisation with a wide ranging commitment to philanthropy around Australia. Funding focus is on community and social welfare, health support, aged and palliative care, education and youth support, arts and cultural heritage and the environment.

The Sir Robert Menzies Memorial Research Scholarship in the Allied Health Sciences – closes 30/06/17
The purpose of the scholarship is to try to improve the health of Australians by supporting an outstanding applicant from one of the non‐medical allied health disciplines, or from an applicant who is working directly in applied clinical research.

The John Burge Trust – closes 30/06/17
The John Burge Trust was established by the late John Burge to assist people with tuberculosis and support work towards the prevention and cure of the disease. This can include: educational programs for health workers; aid and help for tuberculosis sufferers and who by reason of the disease are disabled; medication; research.

Shepherd Foundation Research Grants – closes 01/07/17 and 15/09/17
For research projects in all aspects of preventative medicine and/or occupational medicine. Applicants may apply for funding of one, two or three years.

Lung Cancer Research Foundation Grants 2017 – closes 01/07/17
Lung cancer projects focused on one or more of the following: basic science; translational research; clinical research; supportive care; quality of care/outcomes.

GlaxoSmithKline Australia Award for Research Excellence – closes 10/07/17
Recognition for an outstanding researcher with a demonstrated track record of significant work in human medical health, and for whom the award will facilitate career development and further achievements.

The Alan Westcare Project Grant – closes 31/07/17
The Alan King Westcare Project Grant is a 12 month $50,000 grant to available to laboratory, clinical and epidemiological research into the cause, diagnosis, prevention and treatment of respiratory infections such as tuberculosis.

CSL Centenary Fellowships 2017 – closes 31/07/17
To foster excellence in Australian medical research by supporting mid-career Australian scientists to pursue world class medical research. The fellowship provides for a full-time salary (generally equivalent to a Senior Research Fellow C1 level) plus research costs and/or a post-doctoral research assistant. The breakdown is determined by the Fellow, in conjunction with the employing institution at the commencement of the Fellowship. The fellowships are primarily awarded for discovery and translational research with a focus on rare and serious diseases, immunology, and inflammation. However, those who meet the eligibility are strongly encouraged to submit an application for their medical research project.

Centenary Institute Medical Innovation Award 2017 – closes 31/07/17
The Prize focuses on creativity – the essential ingredient in all human endeavour, whether in science, art or marketing. It will be presented to the biomedical research scientist based in Australia who demonstrates the greatest creativity in their scientific approach in a given year. Valued at $36,000.

Government of Western Australia – 2017 Healthway Intervention Research Grants – closing date TBA
Intervention Research Grants will fund applications that demonstrate a clear pathway to a health promotion program or intervention in WA, including policy interventions. Applicants are required to focus on at least one of Healthway’s priority areas of tobacco smoking control, reducing harm from alcohol, good nutrition promotion, physical activity promotion (including reducing sedentary behaviour), mental health promotion, skin cancer prevention, reducing harm from illicit drugs and Aboriginal health. Applications in other areas of health promotion will not be considered.

Rolling Grants

Boehringer Ingelheim Fonds Travel Grants
Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

Baxalta Bioscience Grants – Medical Education & Fellowship Grants
Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

Coopers Brewery Foundation – current round closes 01/08/2017
Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

The Balnaves Foundation
The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

 

PhD Scholarships

PhD Scholarship opportunity available at the University of Newcastle: Maternal and early life nutritional status and respiratory health of the offspring.

Please see flyer for more information [PDF]

Applications close 31st July, 2017.

Research Project and Survey Requests

‘Usual’ antenatal asthma management

Dear Colleague,

Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma management consists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

Ethics approval has been granted for this study. All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser: https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

 

Recruiting for new study investigating the effects of ambulatory oxygen therapy via portable concentrator in interstitial lung disease

Researchers at Austin Health are currently recruiting patients with chronic interstitial lung disease and exertional desaturation (< 90% on room air during the 6-minute walk test) for a randomized controlled trial investigating the effects of ambulatory oxygen therapy via portable concentrators. Inclusion and exclusion criteria are in the link below. 

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371748&isReview=true  

If you wish to discuss possible patients for screening and enrolment or receive further information, please contact Yet Hong Khor on 03 9496 5390 or YetHong.Khor@austin.org.au.

This study has been approved by the Austin Health Human Research Ethics Committee.

 

Are you interested in helping us further our understanding of healthcare professionals’ perceptions of asthma using an innovative method – drawings?

If so, and you are a healthcare professional, you are invited to take part in a research study exploring the use of drawings to further understanding of healthcare professionals’ perceptions of the experience of asthma.

An emerging approach for investigating people’s perspectives of illness is the use of drawings. Despite the high prevalence of asthma, there is yet to be research using drawing to explore healthcare professionals’ perceptions of the experience of asthma in the Australian population. Drawings may be useful for expression and could increase our understanding of the perspective of healthcare professionals involved in asthma management. The total time commitment is expected to be approximately one hour. You will be reimbursed for your time.

If you would like more details or would like to take part, please contact the researchers (details below). Thank you!

A/Prof Lorraine Smith, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9036 7079

Melissa Cheung, PhD Candidate, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9351 3710

 

Paediatric PFT needs assessment

We are undertaking a project to assess and address the needs of the global paediatric pulmonology/respirology community for practice guidelines for paediatric pulmonary function testing in both the clinical and research settings.

The first step in this project is to define and understand those needs via a short (less than 5 minute) survey. We ask that you complete this brief survey to help us understand how to best meet the needs of our community. Please click on the link below to complete the survey online.

Survey

Thank you for your time.

Nitin Kapur, Paediatric SIG Convenor

on behalf of 

Members of the American Thoracic Society/European Respiratory Society Infant & Preschool Pulmonary Function Testing Working Group and the European Respiratory Society Pediatric Respiratory and Sleep Physiology Working Group:

Graham Hall, BSc PhD
Jessica Pittman, MD MPH
Padmaja Subbarao, MD MSc FRCP
Claudia Calogero, MD
Stephanie Davis, MD
Margaret Rosenfeld, MD MPH

 

Barriers and Facilitators to Optimal use of Acute Oxygen Therapy in Adults

Dear colleagues,

Our research  team is conducting a study to investigate the  barriers, facilitators and attitudes of health care professionals towards the prescription and delivery of oxygen therapy in the acute care setting. We hope that the results from this study will provide information that will be used to inform and facilitate the translation of evidence based guidelines into clinical practice.

As a clinician who delivers care to patients who use oxygen therapy, we understand that your views and opinions are important. You are invited to participate in this voluntary online survey. It is expected that this should take no longer than 15 minutes. There are no correct or incorrect responses, this survey is designed to explore your opinions regarding acute oxygen therapy.

This study has been granted ethics approval by Hunter New England Human Research Ethics Committee  (Approval number: 16/04/20/5.03) and the University of Newcastle Human Research Ethics Committee (Reference Number: H-2016-0222). For further information you can view the participant information HERE.

There are no anticipated risks to you for taking part in this survey. Information that you provide will be anonymous and remain confidential. Only those directly involved in this research have access to any answers that you provide. Participation in the survey implies consent and can be completed by clicking  the  OXYGEN SURVEY LINK HERE.

Please feel free to contact us directly if you have any questions regarding this research.

We thank you in advance for participating and ask you to consider forwarding this survey to other colleagues, who also deliver care to patients with oxygen therapy.

Kind Regards

Professor Vanessa McDonald
Professor Peter Wark
Joyce Cousins (PhD Scholar)
Contact: joyce.cousins@uon.edu.au

 
 

 

 

 

 
 
 
 
 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 1.08 OCTOBER 2016

Research Roundup:

October 2016

.
 

Welcome Message

Abstract submissions for the TSANZSRS 2017 close tomorrow! Please submit your abstracts and look into applying for the abstract-linked awards.

We are now happy to announce that TSANZ has finalised an en bloc membership agreement with the ERS. Membership to the European Respiratory Society will be available to all TSANZ members upon renewal of your TSANZ membership, at an additional heavily discounted rate. This will give members who choose to take out ERS membership highly discounted member benefits including access to the digital ERS Journal, international ERS awards, and various discounted rates, such as for the ERS Congress.

There is also good news for COPD researchers. We have now opened the new Boehringer ingelheim COPD Research Award. This award will build capacity and foster the development of research in the area of COPD through the support of pilot studies, proof of concept and feasibility studies. Please see below for more detail or visit our awards page.

Lastly, I urge you once again to look to the surveys section of this newsletter. Please support your fellow TSANZ researchers and consider participating in these. We all know how difficult collecting the necessary data can be and this is a good opportunity for collegiate support. 

Enjoy your October Research Roundup,

Prof Phil Hansbro

Chair, Research Sub-Committee

Special Awards and Fellows

Nominations for the TSANZ Research medal are now open to all members of TSANZ. The Research Medal is awarded in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand.

The award recognises an individual who has demonstrated sustained excellence in their field of research and is open to all financial members of TSANZ, including Associate members. Please consider nominating yourself or a Colleague for this prestigious award.

The Society Medal and 50th Anniversary Medal for education applications are also open.
For more information http://www.thoracic.org.au/researchawards/tsanz-awards-by-nomination 
Nominations close: 24th November

A call for TSANZ Fellows is currently open to members from all professions who demonstrate exceptional contribution to the field of respiratory health in Australia or New Zealand. If the Fellow status is approved, the member will be able to use the post nominal FThorSoc and will be able to continue to do so whilst a financial member of TSANZ.The main aims of the Fellow status are:

1. To recognise expertise and experience in respiratory medicine and/or research and/or respiratory health service provision.
2. To acknowledge a major contribution and commitment to advancing respiratory health in Australia and/ or New Zealand.

Applications close 24th November. Please see http://www.thoracic.org.au/about-us/fellow-of-thoracic-society-australia-new-zealand for more info.

The following articles will take you to thelimbic.com

Thoracic items targeted in MBS review. Proposed changes to spirometry and sleep study items will address problems of under-utilisation of spirometry and over-utilisation of sleep studies as well as better remunerate health care professionals. Read More. 

Holy grail: Reducing the burden of asthma in South Australia. In this month’s Holy Grail Dr Kristen Carson, a Senior Medical Research Scientist at The Queen Elizabeth Hospital in Adelaide, tells us about her work creating an evidence-based solution to reducing the high rate of asthma related hospitalisations in South Australia. Read More.

Simple home based pulmonary rehab offers hope for some COPD patients. Home-based pulmonary rehabilitation delivered using minimal resources has similar – and in some cases even superior – outcomes to centre-based pulmonary rehabilitation, Australian researchers have found. Read More.

Experts still think more is not better. Australian and New Zealand experts have reiterated their rationale for a target oxygen saturation range of 92-96% instead of the British Thoracic Society recommendation of 94-98%. Read More.

Black lung crisis escalates. A 54-year-old coal miner from Queensland has been confirmed as the 15th case of pneumoconiosis following a re-emergence of the disease last year. Read More.

Potential role for Vitamin D in asthma. A Cochrane review has provided more robust evidence that adding vitamin D supplements to routine asthma management plans may benefit patients. We caught up with the lead author to find out more. Read More.

+ Experts respond. They note that the finding that vitamin D protected against severe asthma attacks is based mainly on results from adults and may not be applicable to children. Read More.

Travel opportunities for APSR Young Investigator members

Award opportunities for APSR Young Investigator members to participate in the APSR-ISRD Joint Session at ATS International Conference, Washington DC in 2017.

Individuals who submit an abstract to ATS 2017 will have a chance to receive a travel award.

View the APSR flyer for more information 

Research Project and Survey Requests

Barriers and facilitators to optimal use of acute oxygen therapy in adults

Dear colleagues,

Our research  team is conducting a study to investigate the  barriers, facilitators and attitudes of health care professionals towards the prescription and delivery of oxygen therapy in the acute care setting. We hope that the results from this study will provide information that will be used to inform and facilitate the translation of evidence based guidelines into clinical practice.

As a clinician who delivers care to patients who use oxygen therapy, we understand that your views and opinions are important. You are invited to participate in this voluntary online survey. It is expected that this should take no longer than 15 minutes. There are no correct or incorrect responses, this survey is designed to explore your opinions regarding acute oxygen therapy.

This study has been granted ethics approval by Hunter New England Human Research Ethics Committee  (Approval number: 16/04/20/5.03) and the University of Newcastle Human Research Ethics Committee (Reference Number: H-2016-0222). For further information you can view the participant information HERE

There are no anticipated risks to you for taking part in this survey. Information that you provide will be anonymous and remain confidential. Only those directly involved in this research have access to any answers that you provide. Participation in the survey implies consent and can be completed by clicking  the  OXYGEN SURVEY LINK HERE

Please feel free to contact us directly if you have any questions regarding this research.

We thank you in advance for participating and ask you to consider forwarding this survey to other colleagues, who also deliver care to patients with oxygen therapy.

Kind Regards

Professor Vanessa McDonald
Professor Peter Wark
Joyce Cousins (PhD Scholar)
Contact: joyce.cousins@uon.edu.au

Inhaled Liposomal Amikacin for treatment resistant MAC infection – a randomised control trial enrolling now.

Dear TSANZ members,
There is currently an industry sponsored RCT of Nebulised Liposomal Amikacin for pulmonary MAC infection which has failed six months of standard therapy or relapsed after treatment. This is the first RCT of a novel compound for NTM infection. Inclusion and exclusion criteria are in the link below.

https://clinicaltrials.gov/ct2/show/NCT02344004?term=LAI&rank=3

The CONVERT STUDY is an international, multi-centre study and there are a number of study sites in Australia and New Zealand. The study sponsor is prepared to pay for travel and accommodation expenses for people in regional areas to travel to study sites.
If you wish to discuss possible patients for screening and enrolment, I can be contacted via email at andrew.burke@health.qld.gov.au, and I can direct you to your nearest study site.

Dr Andrew Burke
Thoracic and Infectious Diseases Physician
The Prince Charles Hospital, Brisbane
(study PI, no conflicts)

Perioperative care of patients with OSA: A survey of beliefs and management approaches amongst Australian clinicians

Obstructive sleep apnoea (OSA) has a rising prevalence in the general population and in those presenting for surgery. It is an established risk factor for increased incidence of peri-operative and post-operative complications. There are currently no consensus-based recommendations on management of these patients in Australia. We wish to conduct a survey of specialties involved in the care of these patients to examine current practice and beliefs in the perioperative management of OSA. The results will be reviewed by the Respiratory and Sleep Department at St Vincent’s Hospital Melbourne, to identify  current trends in practice, and to ultimately guide towards a consensus approach in this field.

The survey link is: https://www.surveymonkey.com/r/perioposa

Dr Chong Weng Ong | Respiratory and Sleep Consultant | St Vincent’s Hospital Melbourne

Joy Sha | Respiratory and Sleep Registrar | St Vincent’s Hospital Melbourne

COPD survey invitation for Physio, Primary Care and Respiratory Nurse SIG

Dear Colleague

Our research team is conducting a survey to understand physiotherapist’s, occupational therapist’s, nurse’s, social worker’s and other allied health professionals’ knowledge and practice behaviours regarding advance care planning in patients with COPD. From the results of this study we hope to develop educational resources to assist health professionals when caring for this patient group.

We invite to participate in a survey, that should take only 10-15 minutes to complete. Several disciplines are represented in the overall survey, however you will be directed to only those questions relevant to your discipline.

Ethics approval has been granted for this study from the University of Sydney. All responses will be anonymous and confidential. No personal information that could identify you is being collected and your email address will not be linked to your survey response. Your consent to participate in this study is implied by completing the survey.

Further information about this research study is provided in the enclosed document [DOWNLOAD]. If you have any questions regarding this research, please do not hesitate to contact Dr Rebecca Disler directly. Thank you in advance for participating.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser: https://www.surveymonkey.com/r/ACPHealthProf

Kind regards

Dr Rebecca Disler | Senior Lecturer in Chronic Disease | The University of Sydney
Email:
 rebecca.disler@sydney.edu.au  | Tel: 0406 876 587

Dr Natasha Smallwood | Respiratory Physician Department of Respiratory Medicine | The Royal Melbourne Hospital

A/Prof Louis Irving | Respiratory Physician Department of Respiratory Medicine | The Royal Melbourne Hospital
Prof David Currow | Palliative Care Physician Flinders University | Adelaide

STUDENT DECLARATION  Yuxiu Cui will be analysing the study results as the basis for her degree of Bachelor of Advanced Nursing (Honours) at The University of Sydney. This will take place under the supervision of Dr Rebecca Disler.

 
 
 

 

 

 

 
 
 
 
 
 
 
 
 

.

WHY JOIN US?

Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

X